Gene Symbol | Gene ID | Gene Info |
---|---|---|
Runx2
|
ENSMUSG00000039153.10 | runt related transcription factor 2 |
Bcl11a
|
ENSMUSG00000000861.9 | B cell CLL/lymphoma 11A (zinc finger protein) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_24095763_24095931 | Bcl11a | 15177 | 0.134812 | -0.76 | 1.1e-11 | Click! |
chr11_24095108_24095259 | Bcl11a | 14513 | 0.135747 | -0.72 | 7.8e-10 | Click! |
chr11_24084706_24084872 | Bcl11a | 4119 | 0.169879 | -0.68 | 1.1e-08 | Click! |
chr11_24091539_24091690 | Bcl11a | 10944 | 0.140995 | -0.68 | 1.2e-08 | Click! |
chr11_24136189_24136356 | Bcl11a | 6107 | 0.165287 | 0.67 | 2.3e-08 | Click! |
chr17_44736292_44736597 | Runx2 | 204 | 0.809267 | -0.81 | 6.4e-14 | Click! |
chr17_44735810_44736271 | Runx2 | 136 | 0.582703 | -0.81 | 1.0e-13 | Click! |
chr17_44735529_44735680 | Runx2 | 30 | 0.760661 | -0.72 | 4.7e-10 | Click! |
chr17_44827241_44827403 | Runx2 | 12525 | 0.205303 | 0.69 | 6.1e-09 | Click! |
chr17_44735074_44735259 | Runx2 | 200 | 0.836312 | -0.68 | 9.3e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_80468459_80468787 | 63.08 |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
11346 |
0.21 |
chr18_84389765_84390095 | 48.42 |
Gm37216 |
predicted gene, 37216 |
13784 |
0.22 |
chr8_20817574_20818579 | 46.07 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr17_48300203_48300827 | 37.17 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
129 |
0.94 |
chr5_140439026_140439687 | 35.79 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
586 |
0.63 |
chr7_24369770_24370215 | 35.69 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
271 |
0.81 |
chr1_88482769_88483125 | 35.60 |
Gm29538 |
predicted gene 29538 |
20339 |
0.14 |
chr19_55938421_55938984 | 35.21 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40393 |
0.17 |
chr16_92825845_92826239 | 35.05 |
Runx1 |
runt related transcription factor 1 |
32 |
0.98 |
chr9_98298839_98299188 | 34.76 |
Nmnat3 |
nicotinamide nucleotide adenylyltransferase 3 |
2351 |
0.29 |
chr3_94686389_94686586 | 32.76 |
Selenbp2 |
selenium binding protein 2 |
7069 |
0.11 |
chr16_94358214_94358418 | 32.64 |
Gm15310 |
predicted gene 15310 |
996 |
0.44 |
chr13_24419481_24419859 | 31.54 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2446 |
0.22 |
chr7_44484045_44484471 | 31.29 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
259 |
0.76 |
chr16_22899417_22899910 | 31.26 |
Ahsg |
alpha-2-HS-glycoprotein |
4799 |
0.13 |
chr7_141614114_141614913 | 29.76 |
Gm16982 |
predicted gene, 16982 |
766 |
0.53 |
chr11_78981943_78982094 | 29.25 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2813 |
0.25 |
chr6_73530178_73530470 | 29.16 |
Gm4374 |
predicted gene 4374 |
1086 |
0.56 |
chr5_103994149_103994379 | 29.09 |
Gm8200 |
predicted gene 8200 |
4894 |
0.14 |
chr14_14351950_14353283 | 28.35 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr16_92822038_92822326 | 28.34 |
Runx1 |
runt related transcription factor 1 |
3596 |
0.31 |
chr5_34976672_34977186 | 28.24 |
Rgs12 |
regulator of G-protein signaling 12 |
1937 |
0.3 |
chr9_120116339_120116545 | 28.04 |
Slc25a38 |
solute carrier family 25, member 38 |
1453 |
0.2 |
chr3_60602746_60603521 | 27.92 |
Mbnl1 |
muscleblind like splicing factor 1 |
405 |
0.79 |
chr11_95808504_95808830 | 27.81 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr4_46404152_46404582 | 27.33 |
Hemgn |
hemogen |
131 |
0.94 |
chr11_109555645_109556032 | 26.48 |
Arsg |
arylsulfatase G |
12084 |
0.16 |
chr11_115911092_115911332 | 26.41 |
Smim6 |
small integral membrane protein 6 |
805 |
0.41 |
chr16_58661948_58662241 | 26.40 |
Gm49701 |
predicted gene, 49701 |
6850 |
0.13 |
chr7_34985753_34985935 | 26.30 |
Pepd |
peptidase D |
16334 |
0.14 |
chr17_34210626_34210847 | 25.87 |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
3030 |
0.09 |
chr2_79121005_79121302 | 25.28 |
Gm14465 |
predicted gene 14465 |
40442 |
0.17 |
chr4_129416522_129416820 | 25.16 |
Zbtb8b |
zinc finger and BTB domain containing 8b |
15858 |
0.1 |
chr11_105152378_105152540 | 25.06 |
Gm11620 |
predicted gene 11620 |
14161 |
0.13 |
chr5_142920749_142921092 | 24.82 |
Actb |
actin, beta |
14166 |
0.14 |
chr10_54039973_54040637 | 24.75 |
Gm47917 |
predicted gene, 47917 |
23506 |
0.18 |
chr15_84212028_84212722 | 24.44 |
Samm50 |
SAMM50 sorting and assembly machinery component |
10150 |
0.12 |
chr9_64564285_64564586 | 24.36 |
Megf11 |
multiple EGF-like-domains 11 |
17536 |
0.24 |
chr6_88915651_88916398 | 24.27 |
Gm44178 |
predicted gene, 44178 |
3684 |
0.14 |
chr3_115815609_115815956 | 24.08 |
Dph5 |
diphthamide biosynthesis 5 |
72055 |
0.07 |
chr9_102813650_102814074 | 23.67 |
Gm18655 |
predicted gene, 18655 |
7088 |
0.14 |
chr17_35022153_35022457 | 23.62 |
Sapcd1 |
suppressor APC domain containing 1 |
5354 |
0.05 |
chr12_113042691_113042850 | 23.43 |
Pacs2 |
phosphofurin acidic cluster sorting protein 2 |
19435 |
0.09 |
chr7_16340726_16341001 | 23.41 |
Bbc3 |
BCL2 binding component 3 |
27346 |
0.09 |
chr5_139803949_139804524 | 23.23 |
Tmem184a |
transmembrane protein 184a |
3744 |
0.14 |
chr8_88279311_88279642 | 23.10 |
Adcy7 |
adenylate cyclase 7 |
3516 |
0.23 |
chr11_113173900_113174474 | 23.07 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
1110 |
0.61 |
chr15_78413114_78413438 | 23.01 |
Mpst |
mercaptopyruvate sulfurtransferase |
3294 |
0.12 |
chr9_113969020_113969322 | 22.94 |
Ubp1 |
upstream binding protein 1 |
54 |
0.97 |
chr17_24903102_24903421 | 22.87 |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
103 |
0.92 |
chr2_73023761_73024098 | 22.87 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
36688 |
0.12 |
chr10_61412962_61413255 | 22.77 |
Nodal |
nodal |
4864 |
0.13 |
chr15_103257848_103258200 | 22.61 |
Nfe2 |
nuclear factor, erythroid derived 2 |
379 |
0.75 |
chr8_120486990_120488549 | 22.45 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr7_29029916_29030089 | 22.41 |
Gm38979 |
predicted gene, 38979 |
979 |
0.37 |
chr7_100466363_100466639 | 22.17 |
Gm10603 |
predicted gene 10603 |
689 |
0.43 |
chr6_55324727_55325118 | 22.15 |
Aqp1 |
aquaporin 1 |
11510 |
0.14 |
chr1_132374627_132374890 | 22.12 |
Gm15849 |
predicted gene 15849 |
6371 |
0.13 |
chr4_86634855_86635011 | 22.07 |
Gm12551 |
predicted gene 12551 |
3682 |
0.19 |
chr4_86674699_86674850 | 21.88 |
Plin2 |
perilipin 2 |
4714 |
0.21 |
chr19_24534375_24534662 | 21.87 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
21271 |
0.17 |
chr6_118758618_118758929 | 21.85 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
799 |
0.74 |
chr12_4775351_4775514 | 21.79 |
Pfn4 |
profilin family, member 4 |
6093 |
0.1 |
chr15_59065062_59065258 | 21.68 |
Mtss1 |
MTSS I-BAR domain containing 1 |
9696 |
0.23 |
chr18_79257106_79257504 | 21.68 |
Gm2116 |
predicted gene 2116 |
47857 |
0.15 |
chr7_75596194_75596435 | 21.66 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
13725 |
0.19 |
chr7_127091121_127091448 | 21.57 |
AI467606 |
expressed sequence AI467606 |
75 |
0.92 |
chr5_36722522_36722955 | 21.37 |
Gm43701 |
predicted gene 43701 |
25880 |
0.11 |
chr1_24613351_24614205 | 21.33 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr8_120293531_120293822 | 21.19 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
65220 |
0.09 |
chr12_32050211_32050499 | 21.10 |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
10234 |
0.2 |
chr7_142574309_142575453 | 21.07 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr11_96930018_96930218 | 21.06 |
Prr15l |
proline rich 15-like |
724 |
0.45 |
chr3_89870785_89871326 | 21.02 |
She |
src homology 2 domain-containing transforming protein E |
33166 |
0.09 |
chr13_51748138_51748536 | 20.96 |
Sema4d |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
389 |
0.86 |
chr10_127062800_127064205 | 20.93 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr3_60785598_60785915 | 20.90 |
Gm38326 |
predicted gene, 38326 |
2605 |
0.27 |
chr12_76673740_76674235 | 20.85 |
Sptb |
spectrin beta, erythrocytic |
36036 |
0.15 |
chr12_91745616_91746448 | 20.81 |
Ston2 |
stonin 2 |
52 |
0.97 |
chr9_99248394_99248720 | 20.77 |
Cep70 |
centrosomal protein 70 |
2270 |
0.17 |
chr9_62353863_62354050 | 20.72 |
Anp32a |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
9157 |
0.2 |
chr11_57654937_57655124 | 20.71 |
4933426K07Rik |
RIKEN cDNA 4933426K07 gene |
2796 |
0.21 |
chr7_143004700_143005061 | 20.38 |
Tspan32 |
tetraspanin 32 |
166 |
0.92 |
chr7_143005357_143005799 | 20.33 |
Tspan32 |
tetraspanin 32 |
60 |
0.96 |
chr1_88273340_88274063 | 20.19 |
Hjurp |
Holliday junction recognition protein |
582 |
0.6 |
chr5_115514463_115515506 | 20.19 |
Gm13840 |
predicted gene 13840 |
279 |
0.77 |
chr13_83344551_83344924 | 20.10 |
Gm48156 |
predicted gene, 48156 |
155028 |
0.04 |
chr11_118000937_118001229 | 20.08 |
Pgs1 |
phosphatidylglycerophosphate synthase 1 |
288 |
0.83 |
chr12_4872991_4873188 | 20.05 |
Mfsd2b |
major facilitator superfamily domain containing 2B |
1256 |
0.34 |
chr5_143639756_143640070 | 20.00 |
Cyth3 |
cytohesin 3 |
3562 |
0.24 |
chr2_30417882_30418061 | 19.97 |
Ptpa |
protein phosphatase 2 protein activator |
1669 |
0.2 |
chr11_120399334_120399496 | 19.95 |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
15912 |
0.07 |
chr2_173707562_173707972 | 19.93 |
Mir6340 |
microRNA 6340 |
6619 |
0.15 |
chr3_115793348_115794044 | 19.89 |
Gm9889 |
predicted gene 9889 |
78546 |
0.07 |
chr1_168287679_168288893 | 19.77 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr8_114136918_114137088 | 19.77 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
3361 |
0.35 |
chr3_89880567_89880728 | 19.73 |
Gm42809 |
predicted gene 42809 |
32269 |
0.09 |
chr12_103863072_103863984 | 19.71 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr9_58658203_58658373 | 19.62 |
Rec114 |
REC114 meiotic recombination protein |
1004 |
0.53 |
chr1_73038869_73039089 | 19.37 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
14410 |
0.22 |
chr11_69605027_69606271 | 19.36 |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
180 |
0.83 |
chr16_96906661_96906967 | 19.31 |
Gm32432 |
predicted gene, 32432 |
11918 |
0.3 |
chr6_123293239_123293390 | 19.30 |
Clec4e |
C-type lectin domain family 4, member e |
3444 |
0.18 |
chr7_143565396_143565612 | 19.30 |
Cars |
cysteinyl-tRNA synthetase |
489 |
0.66 |
chr17_71264794_71265030 | 19.15 |
Emilin2 |
elastin microfibril interfacer 2 |
117 |
0.96 |
chr11_74572712_74572939 | 19.02 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
17299 |
0.18 |
chr11_102373059_102373635 | 18.97 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
3673 |
0.12 |
chr11_115838815_115839188 | 18.95 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
4678 |
0.11 |
chr10_93882793_93883049 | 18.93 |
Metap2 |
methionine aminopeptidase 2 |
4565 |
0.15 |
chr9_115862887_115863108 | 18.85 |
Gadl1 |
glutamate decarboxylase-like 1 |
46458 |
0.17 |
chr17_74872546_74872923 | 18.85 |
Ttc27 |
tetratricopeptide repeat domain 27 |
10813 |
0.18 |
chr14_118836889_118837234 | 18.79 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
10030 |
0.16 |
chr5_129633260_129633411 | 18.77 |
Gm6139 |
predicted gene 6139 |
9464 |
0.14 |
chr9_110859283_110859465 | 18.74 |
Prss50 |
protease, serine 50 |
1407 |
0.22 |
chr6_28232245_28232573 | 18.70 |
Gm42548 |
predicted gene 42548 |
4604 |
0.16 |
chr4_151958229_151958442 | 18.65 |
Dnajc11 |
DnaJ heat shock protein family (Hsp40) member C11 |
1192 |
0.37 |
chr11_29814877_29815214 | 18.54 |
Eml6 |
echinoderm microtubule associated protein like 6 |
6617 |
0.16 |
chr10_68431410_68431585 | 18.54 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
94270 |
0.07 |
chr9_123481094_123481245 | 18.52 |
Limd1 |
LIM domains containing 1 |
559 |
0.75 |
chr4_140860203_140860394 | 18.50 |
4930515B02Rik |
RIKEN cDNA 4930515B02 gene |
12395 |
0.12 |
chr15_99332834_99333978 | 18.42 |
Fmnl3 |
formin-like 3 |
2321 |
0.16 |
chr17_35104821_35105105 | 18.34 |
Ly6g5c |
lymphocyte antigen 6 complex, locus G5C |
3316 |
0.06 |
chr11_53794666_53795169 | 18.34 |
Gm12216 |
predicted gene 12216 |
958 |
0.43 |
chr7_35557794_35558034 | 18.31 |
Nudt19 |
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
1610 |
0.25 |
chr4_137955229_137955399 | 18.30 |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
37708 |
0.15 |
chr10_75697073_75697253 | 18.28 |
Cabin1 |
calcineurin binding protein 1 |
3212 |
0.18 |
chr9_71166081_71166377 | 18.17 |
Aqp9 |
aquaporin 9 |
1007 |
0.5 |
chr7_116484411_116484562 | 18.06 |
Gm45031 |
predicted gene 45031 |
7918 |
0.14 |
chr10_13874715_13874984 | 18.02 |
Gm32172 |
predicted gene, 32172 |
3569 |
0.16 |
chr3_65658208_65659857 | 17.98 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr6_138424907_138425582 | 17.93 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr5_109557850_109558797 | 17.92 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr2_3657823_3658259 | 17.92 |
Gm13183 |
predicted gene 13183 |
22549 |
0.15 |
chr7_97747129_97747413 | 17.89 |
Aqp11 |
aquaporin 11 |
8982 |
0.16 |
chr12_26469028_26470065 | 17.88 |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
342 |
0.84 |
chr1_133815739_133816262 | 17.88 |
Gm10537 |
predicted gene 10537 |
13528 |
0.13 |
chr5_143057829_143058116 | 17.85 |
Gm43378 |
predicted gene 43378 |
7929 |
0.14 |
chr11_3176082_3176640 | 17.85 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
105 |
0.94 |
chr11_97434692_97435371 | 17.77 |
Arhgap23 |
Rho GTPase activating protein 23 |
1254 |
0.42 |
chr4_154929190_154929525 | 17.77 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
794 |
0.51 |
chr11_11948402_11948621 | 17.74 |
Grb10 |
growth factor receptor bound protein 10 |
2181 |
0.32 |
chr12_91757977_91758292 | 17.72 |
Ston2 |
stonin 2 |
12050 |
0.17 |
chr11_4094091_4094832 | 17.71 |
Mtfp1 |
mitochondrial fission process 1 |
679 |
0.5 |
chr15_83308796_83308956 | 17.53 |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
1810 |
0.31 |
chr3_121474804_121475157 | 17.52 |
Slc44a3 |
solute carrier family 44, member 3 |
14069 |
0.15 |
chr9_123981971_123982159 | 17.47 |
Ccr1l1 |
chemokine (C-C motif) receptor 1-like 1 |
3657 |
0.21 |
chr8_126847582_126847789 | 17.40 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
8452 |
0.21 |
chr7_103793023_103793311 | 17.39 |
Olfr67 |
olfactory receptor 67 |
1346 |
0.19 |
chr1_184645271_184645605 | 17.38 |
Gm37800 |
predicted gene, 37800 |
15965 |
0.15 |
chr11_64962726_64962996 | 17.37 |
Elac2 |
elaC ribonuclease Z 2 |
16177 |
0.22 |
chr7_126042390_126042861 | 17.34 |
Gm44874 |
predicted gene 44874 |
21822 |
0.17 |
chr9_53422571_53422732 | 17.28 |
4930550C14Rik |
RIKEN cDNA 4930550C14 gene |
17353 |
0.14 |
chr3_153791766_153792027 | 17.27 |
5730460C07Rik |
RIKEN cDNA 5730460C07 gene |
191 |
0.91 |
chr13_98275742_98275893 | 17.27 |
Gm21976 |
predicted gene 21976 |
4070 |
0.16 |
chr16_26041382_26041987 | 17.25 |
AU015336 |
expressed sequence AU015336 |
416 |
0.88 |
chr18_54437459_54437788 | 17.25 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
15328 |
0.22 |
chr1_160061804_160061983 | 17.23 |
4930523C07Rik |
RIKEN cDNA 4930523C07 gene |
13269 |
0.15 |
chr7_132738834_132739104 | 17.19 |
Fam53b |
family with sequence similarity 53, member B |
37947 |
0.14 |
chr14_40947517_40947733 | 17.18 |
Tspan14 |
tetraspanin 14 |
13304 |
0.19 |
chr10_121569006_121569830 | 17.16 |
Tbk1 |
TANK-binding kinase 1 |
937 |
0.48 |
chr12_84204731_84204889 | 17.11 |
Gm31513 |
predicted gene, 31513 |
8841 |
0.11 |
chr1_170609925_170610258 | 17.06 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
20230 |
0.16 |
chr1_156745176_156745463 | 17.03 |
Fam20b |
family with sequence similarity 20, member B |
26233 |
0.14 |
chr16_93131459_93131748 | 16.97 |
Gm28003 |
predicted gene, 28003 |
58848 |
0.15 |
chr6_116350734_116350997 | 16.96 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
27 |
0.96 |
chr15_36338833_36339076 | 16.88 |
Gm33936 |
predicted gene, 33936 |
10800 |
0.13 |
chr6_88835003_88835271 | 16.80 |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
3578 |
0.13 |
chr7_143005125_143005349 | 16.75 |
Tspan32 |
tetraspanin 32 |
93 |
0.95 |
chr5_74064910_74065186 | 16.75 |
Usp46 |
ubiquitin specific peptidase 46 |
700 |
0.53 |
chr1_86263989_86264176 | 16.73 |
Armc9 |
armadillo repeat containing 9 |
19516 |
0.1 |
chr4_86634480_86634666 | 16.73 |
Gm12551 |
predicted gene 12551 |
3322 |
0.19 |
chr1_167288765_167288933 | 16.67 |
Mir6347 |
microRNA 6347 |
1276 |
0.29 |
chr6_38342105_38342326 | 16.66 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
12058 |
0.13 |
chr11_11820251_11821045 | 16.64 |
Ddc |
dopa decarboxylase |
2273 |
0.29 |
chr5_116026177_116026354 | 16.59 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
1757 |
0.24 |
chr4_154911160_154911660 | 16.58 |
Prxl2b |
peroxiredoxin like 2B |
12275 |
0.11 |
chr18_60500053_60500204 | 16.58 |
Smim3 |
small integral membrane protein 3 |
1448 |
0.37 |
chrX_94366585_94367598 | 16.56 |
Apoo |
apolipoprotein O |
26 |
0.81 |
chr16_49775478_49775640 | 16.56 |
Gm15518 |
predicted gene 15518 |
23311 |
0.2 |
chr7_78941084_78941246 | 16.55 |
Gm44815 |
predicted gene 44815 |
17279 |
0.13 |
chr1_184656869_184657047 | 16.55 |
Gm37800 |
predicted gene, 37800 |
27485 |
0.12 |
chr16_4012853_4013176 | 16.55 |
Slx4 |
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) |
9244 |
0.1 |
chr13_23697544_23698095 | 16.52 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr8_122551277_122551909 | 16.51 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
264 |
0.83 |
chr1_180821249_180821410 | 16.47 |
H3f3a |
H3.3 histone A |
7386 |
0.1 |
chr6_143068200_143068506 | 16.46 |
C2cd5 |
C2 calcium-dependent domain containing 5 |
1268 |
0.45 |
chr7_45137536_45137715 | 16.42 |
Flt3l |
FMS-like tyrosine kinase 3 ligand |
1193 |
0.13 |
chr2_135700777_135701082 | 16.40 |
Gm14211 |
predicted gene 14211 |
7775 |
0.2 |
chr14_20885136_20885450 | 16.38 |
Gm6128 |
predicted pseudogene 6128 |
28872 |
0.14 |
chr11_117914515_117914889 | 16.36 |
Gm11726 |
predicted gene 11726 |
7203 |
0.13 |
chr4_124606233_124606577 | 16.35 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
37215 |
0.11 |
chr19_59905716_59906059 | 16.35 |
Gm17203 |
predicted gene 17203 |
4825 |
0.24 |
chr10_76642712_76643426 | 16.34 |
Col6a2 |
collagen, type VI, alpha 2 |
19439 |
0.14 |
chr18_21152139_21152308 | 16.29 |
Gm6378 |
predicted pseudogene 6378 |
75114 |
0.09 |
chr6_144901953_144902113 | 16.29 |
Gm22792 |
predicted gene, 22792 |
98401 |
0.06 |
chr11_98581793_98582001 | 16.28 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5471 |
0.11 |
chr8_110988222_110988397 | 16.22 |
Ddx19a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a |
7675 |
0.11 |
chr2_156882426_156882627 | 16.22 |
Sla2 |
Src-like-adaptor 2 |
4552 |
0.09 |
chrX_123500550_123501093 | 16.22 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr2_29870040_29870464 | 16.20 |
2600006K01Rik |
RIKEN cDNA 2600006K01 gene |
65 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.1 | 66.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
16.7 | 66.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
12.7 | 12.7 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
12.0 | 36.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
11.3 | 33.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
10.6 | 31.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
9.6 | 38.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
9.3 | 28.0 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
9.3 | 37.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
8.9 | 26.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
8.7 | 34.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
8.4 | 25.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
8.0 | 8.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
7.8 | 31.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
7.8 | 31.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
7.7 | 38.7 | GO:0070836 | caveola assembly(GO:0070836) |
7.7 | 30.6 | GO:0008228 | opsonization(GO:0008228) |
7.6 | 22.8 | GO:0002432 | granuloma formation(GO:0002432) |
7.5 | 22.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
7.4 | 22.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
7.3 | 44.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
7.3 | 21.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
7.2 | 36.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
7.2 | 14.3 | GO:0015793 | glycerol transport(GO:0015793) |
7.0 | 28.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
6.9 | 34.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
6.9 | 27.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
6.9 | 13.7 | GO:0050904 | diapedesis(GO:0050904) |
6.8 | 27.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
6.8 | 6.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
6.8 | 67.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
6.7 | 20.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
6.7 | 20.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
6.6 | 26.3 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
6.6 | 19.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
6.5 | 39.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
6.5 | 6.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
6.5 | 32.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
6.3 | 19.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
6.3 | 19.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
6.3 | 31.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
6.3 | 25.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
6.2 | 18.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
6.2 | 18.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
6.2 | 18.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
6.1 | 24.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
6.1 | 30.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
6.1 | 36.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
6.0 | 18.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
6.0 | 18.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
6.0 | 17.9 | GO:0035483 | gastric emptying(GO:0035483) |
6.0 | 17.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
5.9 | 23.8 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
5.9 | 11.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
5.9 | 23.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
5.9 | 29.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
5.9 | 23.5 | GO:0032264 | IMP salvage(GO:0032264) |
5.7 | 11.5 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
5.7 | 62.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
5.6 | 22.6 | GO:0007296 | vitellogenesis(GO:0007296) |
5.6 | 11.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
5.6 | 16.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
5.6 | 22.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
5.6 | 16.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
5.5 | 16.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
5.5 | 11.0 | GO:0010985 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
5.5 | 16.5 | GO:0036394 | amylase secretion(GO:0036394) |
5.5 | 11.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
5.5 | 27.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
5.4 | 16.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
5.4 | 16.3 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
5.4 | 5.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
5.4 | 16.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
5.3 | 16.0 | GO:0008050 | female courtship behavior(GO:0008050) |
5.2 | 10.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
5.2 | 15.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
5.2 | 10.3 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
5.1 | 15.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
5.1 | 5.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
5.0 | 15.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
5.0 | 20.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
5.0 | 15.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.0 | 20.1 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
5.0 | 20.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
5.0 | 15.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
5.0 | 39.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
5.0 | 14.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
5.0 | 14.9 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
4.9 | 9.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.8 | 29.0 | GO:1901563 | response to camptothecin(GO:1901563) |
4.8 | 4.8 | GO:0070384 | Harderian gland development(GO:0070384) |
4.8 | 14.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
4.8 | 24.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
4.8 | 23.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
4.8 | 19.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
4.7 | 19.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
4.7 | 4.7 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
4.7 | 9.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
4.7 | 18.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.6 | 9.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
4.6 | 4.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
4.5 | 4.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
4.5 | 4.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
4.5 | 13.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
4.5 | 22.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
4.5 | 8.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.5 | 13.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
4.4 | 17.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
4.4 | 22.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
4.4 | 13.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
4.4 | 13.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
4.3 | 47.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
4.3 | 4.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
4.3 | 43.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
4.3 | 12.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.3 | 12.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.3 | 4.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
4.3 | 12.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
4.2 | 8.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
4.2 | 4.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
4.2 | 4.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
4.2 | 8.4 | GO:0036166 | phenotypic switching(GO:0036166) |
4.2 | 37.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
4.2 | 25.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
4.2 | 8.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
4.2 | 29.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
4.2 | 8.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
4.2 | 20.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
4.2 | 78.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
4.1 | 4.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
4.1 | 28.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
4.1 | 61.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
4.1 | 16.5 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
4.1 | 8.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
4.1 | 24.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
4.1 | 16.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
4.1 | 8.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
4.1 | 4.1 | GO:0043366 | beta selection(GO:0043366) |
4.1 | 16.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
4.0 | 12.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
4.0 | 24.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
4.0 | 12.0 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
4.0 | 16.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.0 | 8.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
4.0 | 16.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
4.0 | 4.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
4.0 | 68.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
4.0 | 8.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
4.0 | 4.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
4.0 | 7.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
4.0 | 23.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.9 | 31.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
3.9 | 15.7 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.9 | 3.9 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
3.9 | 11.6 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
3.9 | 11.6 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
3.8 | 11.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
3.8 | 26.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.8 | 15.4 | GO:0018214 | protein carboxylation(GO:0018214) |
3.8 | 3.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
3.8 | 7.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
3.8 | 3.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
3.8 | 30.5 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
3.8 | 19.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.8 | 22.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
3.7 | 37.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
3.7 | 11.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
3.7 | 67.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
3.7 | 14.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
3.7 | 11.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
3.7 | 11.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
3.7 | 11.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.7 | 47.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
3.7 | 3.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
3.7 | 11.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.6 | 14.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
3.6 | 32.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
3.6 | 3.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
3.6 | 14.5 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
3.6 | 3.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
3.6 | 7.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
3.6 | 14.4 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
3.6 | 10.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
3.6 | 17.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.6 | 24.9 | GO:0015825 | L-serine transport(GO:0015825) |
3.6 | 7.1 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
3.6 | 39.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
3.5 | 3.5 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
3.5 | 3.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
3.5 | 10.6 | GO:0000087 | mitotic M phase(GO:0000087) |
3.5 | 10.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.5 | 7.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
3.5 | 7.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
3.5 | 14.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
3.5 | 7.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
3.5 | 10.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
3.5 | 3.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
3.4 | 6.9 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
3.4 | 13.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
3.4 | 10.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.4 | 34.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
3.4 | 27.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
3.4 | 10.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.4 | 10.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
3.4 | 6.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
3.4 | 10.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.4 | 10.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
3.4 | 6.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.4 | 13.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
3.3 | 23.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
3.3 | 3.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
3.3 | 10.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
3.3 | 30.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
3.3 | 6.7 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
3.3 | 26.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
3.3 | 3.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
3.3 | 10.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
3.3 | 3.3 | GO:0034204 | lipid translocation(GO:0034204) |
3.3 | 9.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
3.3 | 6.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.3 | 13.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
3.3 | 9.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
3.3 | 65.3 | GO:0048821 | erythrocyte development(GO:0048821) |
3.3 | 9.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.3 | 9.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.3 | 19.6 | GO:0032782 | bile acid secretion(GO:0032782) |
3.3 | 16.3 | GO:0015879 | carnitine transport(GO:0015879) |
3.2 | 6.5 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
3.2 | 22.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
3.2 | 3.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
3.2 | 16.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
3.2 | 12.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
3.2 | 12.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
3.2 | 9.7 | GO:0015817 | histidine transport(GO:0015817) |
3.2 | 9.6 | GO:0042117 | monocyte activation(GO:0042117) |
3.2 | 9.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.2 | 12.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
3.2 | 3.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
3.2 | 25.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
3.1 | 15.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
3.1 | 9.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.1 | 3.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
3.1 | 9.3 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
3.1 | 15.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.1 | 24.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
3.1 | 37.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
3.1 | 30.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.1 | 9.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.1 | 6.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
3.1 | 12.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
3.0 | 9.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.0 | 33.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
3.0 | 15.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
3.0 | 9.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
3.0 | 6.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
3.0 | 6.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
3.0 | 18.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
3.0 | 12.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
3.0 | 15.0 | GO:0018101 | protein citrullination(GO:0018101) |
3.0 | 3.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
3.0 | 8.9 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
3.0 | 23.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
3.0 | 5.9 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
3.0 | 11.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.0 | 3.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
2.9 | 8.8 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
2.9 | 8.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.9 | 14.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
2.9 | 26.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.9 | 11.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.9 | 8.7 | GO:0044838 | cell quiescence(GO:0044838) |
2.9 | 29.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.9 | 11.6 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
2.9 | 5.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.9 | 2.9 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
2.9 | 11.6 | GO:0015671 | oxygen transport(GO:0015671) |
2.9 | 2.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.9 | 8.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.9 | 17.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
2.9 | 20.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
2.9 | 5.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
2.9 | 8.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.9 | 2.9 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
2.9 | 23.0 | GO:0042730 | fibrinolysis(GO:0042730) |
2.9 | 11.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
2.9 | 8.6 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.9 | 2.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
2.9 | 5.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
2.9 | 2.9 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
2.8 | 8.5 | GO:0009629 | response to gravity(GO:0009629) |
2.8 | 19.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.8 | 2.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.8 | 5.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.8 | 11.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
2.8 | 8.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.8 | 11.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.8 | 11.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
2.8 | 11.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.8 | 14.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.8 | 8.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.8 | 5.6 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
2.8 | 5.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.8 | 11.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
2.8 | 14.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.8 | 8.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
2.8 | 2.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
2.8 | 2.8 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
2.8 | 41.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.8 | 13.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
2.8 | 2.8 | GO:0036258 | multivesicular body assembly(GO:0036258) |
2.7 | 16.5 | GO:0071404 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
2.7 | 8.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.7 | 8.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
2.7 | 38.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
2.7 | 21.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
2.7 | 19.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.7 | 13.6 | GO:0051784 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
2.7 | 5.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.7 | 40.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.7 | 2.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.7 | 13.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.7 | 18.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.7 | 2.7 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
2.7 | 50.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
2.7 | 2.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
2.7 | 13.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.7 | 15.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.7 | 18.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.6 | 21.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
2.6 | 18.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.6 | 5.3 | GO:1902075 | cellular response to salt(GO:1902075) |
2.6 | 7.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.6 | 7.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
2.6 | 13.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.6 | 78.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
2.6 | 2.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.6 | 7.8 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.6 | 2.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.6 | 7.8 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
2.6 | 2.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
2.6 | 7.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.6 | 7.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.6 | 12.9 | GO:0006563 | L-serine metabolic process(GO:0006563) |
2.6 | 51.2 | GO:0006301 | postreplication repair(GO:0006301) |
2.6 | 5.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
2.6 | 7.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.6 | 17.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.5 | 2.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.5 | 32.9 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
2.5 | 20.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
2.5 | 15.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.5 | 5.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.5 | 2.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
2.5 | 7.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
2.5 | 10.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
2.5 | 15.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.5 | 5.0 | GO:0051029 | rRNA transport(GO:0051029) |
2.5 | 7.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.5 | 4.9 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
2.5 | 14.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.5 | 7.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.5 | 2.5 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
2.5 | 14.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
2.5 | 7.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.4 | 7.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.4 | 7.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.4 | 4.9 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
2.4 | 2.4 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
2.4 | 14.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
2.4 | 17.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.4 | 2.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.4 | 4.9 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
2.4 | 4.9 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
2.4 | 21.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
2.4 | 4.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.4 | 7.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.4 | 7.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.4 | 2.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.4 | 9.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
2.4 | 26.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
2.4 | 7.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
2.4 | 2.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
2.4 | 4.7 | GO:0036302 | atrioventricular canal development(GO:0036302) |
2.4 | 4.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
2.3 | 4.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
2.3 | 2.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.3 | 2.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
2.3 | 7.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.3 | 2.3 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
2.3 | 2.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
2.3 | 11.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.3 | 18.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
2.3 | 2.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
2.3 | 6.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
2.3 | 16.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.3 | 13.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.3 | 9.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.3 | 4.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
2.3 | 9.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
2.3 | 11.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.3 | 9.1 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
2.3 | 27.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.3 | 15.9 | GO:0032060 | bleb assembly(GO:0032060) |
2.3 | 4.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
2.3 | 2.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
2.3 | 13.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.3 | 27.1 | GO:0042407 | cristae formation(GO:0042407) |
2.3 | 4.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.3 | 6.8 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
2.3 | 2.3 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
2.2 | 15.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
2.2 | 11.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.2 | 13.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.2 | 2.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.2 | 20.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
2.2 | 11.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.2 | 11.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.2 | 2.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
2.2 | 6.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.2 | 11.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.2 | 11.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.2 | 8.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.2 | 4.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.2 | 10.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
2.2 | 4.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
2.2 | 8.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.2 | 6.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.2 | 6.5 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.2 | 8.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
2.2 | 52.2 | GO:0014823 | response to activity(GO:0014823) |
2.2 | 10.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.2 | 15.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
2.2 | 2.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
2.2 | 6.5 | GO:0007525 | somatic muscle development(GO:0007525) |
2.2 | 8.7 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
2.2 | 2.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.2 | 6.5 | GO:0032439 | endosome localization(GO:0032439) |
2.2 | 36.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
2.1 | 8.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
2.1 | 6.4 | GO:0018343 | protein farnesylation(GO:0018343) |
2.1 | 6.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.1 | 6.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.1 | 12.8 | GO:0006477 | protein sulfation(GO:0006477) |
2.1 | 8.5 | GO:0044351 | macropinocytosis(GO:0044351) |
2.1 | 2.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
2.1 | 2.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
2.1 | 14.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
2.1 | 6.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
2.1 | 4.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.1 | 6.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.1 | 4.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
2.1 | 4.2 | GO:0050832 | defense response to fungus(GO:0050832) |
2.1 | 8.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
2.1 | 6.3 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
2.1 | 4.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
2.1 | 6.3 | GO:0072537 | fibroblast activation(GO:0072537) |
2.1 | 10.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.1 | 2.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
2.1 | 6.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.1 | 29.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
2.1 | 4.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
2.1 | 2.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
2.0 | 6.1 | GO:0061511 | centriole elongation(GO:0061511) |
2.0 | 10.2 | GO:0048539 | bone marrow development(GO:0048539) |
2.0 | 2.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.0 | 6.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.0 | 10.2 | GO:0018904 | ether metabolic process(GO:0018904) |
2.0 | 2.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.0 | 2.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.0 | 6.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.0 | 4.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.0 | 2.0 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
2.0 | 6.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.0 | 2.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
2.0 | 4.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.0 | 14.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.0 | 6.0 | GO:0015819 | lysine transport(GO:0015819) |
2.0 | 2.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
2.0 | 4.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.0 | 2.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
2.0 | 13.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
2.0 | 4.0 | GO:0006116 | NADH oxidation(GO:0006116) |
2.0 | 4.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
2.0 | 7.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
2.0 | 7.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.0 | 7.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.0 | 4.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.0 | 5.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.0 | 19.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.0 | 11.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.0 | 5.9 | GO:0003383 | apical constriction(GO:0003383) |
2.0 | 2.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.0 | 5.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.0 | 9.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
2.0 | 3.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
2.0 | 11.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
2.0 | 3.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.9 | 11.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.9 | 5.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.9 | 3.9 | GO:0002215 | defense response to nematode(GO:0002215) |
1.9 | 11.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.9 | 1.9 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.9 | 5.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.9 | 1.9 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
1.9 | 17.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.9 | 1.9 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
1.9 | 7.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.9 | 7.6 | GO:0036233 | glycine import(GO:0036233) |
1.9 | 5.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.9 | 15.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.9 | 1.9 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.9 | 1.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.9 | 7.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.9 | 7.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.9 | 3.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.9 | 3.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.9 | 18.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.9 | 16.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.9 | 5.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.9 | 5.6 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.9 | 14.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.9 | 5.6 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.9 | 7.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.9 | 1.9 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
1.9 | 3.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.8 | 5.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.8 | 3.7 | GO:0061515 | myeloid cell development(GO:0061515) |
1.8 | 14.8 | GO:0034063 | stress granule assembly(GO:0034063) |
1.8 | 3.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.8 | 11.0 | GO:0016266 | O-glycan processing(GO:0016266) |
1.8 | 3.7 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
1.8 | 62.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.8 | 1.8 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.8 | 9.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.8 | 3.7 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.8 | 1.8 | GO:0072718 | response to cisplatin(GO:0072718) |
1.8 | 12.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.8 | 21.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.8 | 9.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.8 | 5.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.8 | 10.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.8 | 7.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.8 | 5.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.8 | 7.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.8 | 5.4 | GO:0015886 | heme transport(GO:0015886) |
1.8 | 1.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.8 | 5.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.8 | 3.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.8 | 5.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.8 | 7.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.8 | 9.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
1.8 | 3.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.8 | 1.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.8 | 5.4 | GO:0000237 | leptotene(GO:0000237) |
1.8 | 9.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.8 | 5.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.8 | 1.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.8 | 3.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.8 | 12.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.8 | 8.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.8 | 14.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.8 | 30.2 | GO:0001562 | response to protozoan(GO:0001562) |
1.8 | 7.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
1.8 | 5.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.8 | 1.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.8 | 3.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.8 | 8.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.8 | 7.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.8 | 3.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.8 | 1.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.8 | 1.8 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.8 | 3.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.8 | 3.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.7 | 3.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.7 | 20.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.7 | 3.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.7 | 13.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.7 | 12.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.7 | 5.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.7 | 5.2 | GO:0001555 | oocyte growth(GO:0001555) |
1.7 | 6.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.7 | 3.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
1.7 | 17.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.7 | 5.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.7 | 32.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.7 | 5.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.7 | 6.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.7 | 1.7 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.7 | 5.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.7 | 1.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.7 | 6.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.7 | 8.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.7 | 8.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.7 | 8.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.7 | 10.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
1.7 | 13.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
1.7 | 1.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.7 | 3.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.7 | 3.4 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.7 | 3.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.7 | 3.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.7 | 8.5 | GO:0060613 | fat pad development(GO:0060613) |
1.7 | 6.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.7 | 5.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.7 | 5.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.7 | 5.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.7 | 3.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.7 | 3.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.7 | 11.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.7 | 5.1 | GO:0015889 | cobalamin transport(GO:0015889) |
1.7 | 6.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.7 | 33.7 | GO:0006953 | acute-phase response(GO:0006953) |
1.7 | 1.7 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.7 | 8.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.7 | 1.7 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
1.7 | 6.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.7 | 5.0 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
1.7 | 6.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.7 | 3.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.7 | 13.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.7 | 6.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.7 | 5.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.7 | 3.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.7 | 19.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.6 | 4.9 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.6 | 4.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.6 | 3.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.6 | 11.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.6 | 23.0 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
1.6 | 9.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.6 | 6.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.6 | 9.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.6 | 3.3 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.6 | 18.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.6 | 6.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.6 | 3.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.6 | 6.5 | GO:0006907 | pinocytosis(GO:0006907) |
1.6 | 3.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.6 | 3.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.6 | 8.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.6 | 8.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.6 | 3.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.6 | 1.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.6 | 3.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.6 | 14.6 | GO:0051923 | sulfation(GO:0051923) |
1.6 | 6.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.6 | 29.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.6 | 4.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.6 | 3.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
1.6 | 8.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.6 | 11.3 | GO:0030575 | nuclear body organization(GO:0030575) |
1.6 | 9.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.6 | 1.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
1.6 | 3.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.6 | 1.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.6 | 3.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.6 | 8.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.6 | 3.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.6 | 31.8 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
1.6 | 1.6 | GO:0010165 | response to X-ray(GO:0010165) |
1.6 | 6.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.6 | 7.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.6 | 1.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.6 | 9.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.6 | 14.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.6 | 1.6 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
1.6 | 1.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
1.6 | 6.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.6 | 3.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.6 | 3.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.6 | 3.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.6 | 17.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
1.6 | 14.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
1.6 | 9.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.6 | 4.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.6 | 1.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.6 | 6.2 | GO:0016264 | gap junction assembly(GO:0016264) |
1.6 | 4.7 | GO:0000012 | single strand break repair(GO:0000012) |
1.6 | 4.7 | GO:0045006 | DNA deamination(GO:0045006) |
1.5 | 4.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.5 | 6.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.5 | 9.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.5 | 7.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.5 | 1.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.5 | 3.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.5 | 15.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.5 | 4.6 | GO:0048254 | snoRNA localization(GO:0048254) |
1.5 | 4.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.5 | 4.6 | GO:0050779 | RNA destabilization(GO:0050779) |
1.5 | 9.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.5 | 12.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.5 | 1.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
1.5 | 4.6 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
1.5 | 13.7 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.5 | 1.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.5 | 16.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
1.5 | 10.6 | GO:0046697 | decidualization(GO:0046697) |
1.5 | 6.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.5 | 4.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.5 | 12.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.5 | 3.0 | GO:0001774 | microglial cell activation(GO:0001774) |
1.5 | 6.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.5 | 1.5 | GO:0006403 | RNA localization(GO:0006403) |
1.5 | 4.5 | GO:0061010 | gall bladder development(GO:0061010) |
1.5 | 6.0 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
1.5 | 1.5 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.5 | 3.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.5 | 3.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.5 | 12.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.5 | 3.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
1.5 | 3.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.5 | 22.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.5 | 6.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.5 | 1.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.5 | 10.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
1.5 | 5.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.5 | 13.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.5 | 1.5 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
1.5 | 1.5 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
1.5 | 11.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.5 | 2.9 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
1.5 | 19.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.5 | 4.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.5 | 2.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.5 | 2.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.5 | 8.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.4 | 4.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
1.4 | 5.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.4 | 14.4 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
1.4 | 4.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.4 | 5.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.4 | 2.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.4 | 4.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.4 | 8.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.4 | 2.9 | GO:0050955 | thermoception(GO:0050955) |
1.4 | 1.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.4 | 48.5 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
1.4 | 5.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.4 | 7.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.4 | 4.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.4 | 4.3 | GO:0010039 | response to iron ion(GO:0010039) |
1.4 | 4.2 | GO:0040031 | snRNA modification(GO:0040031) |
1.4 | 11.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.4 | 2.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
1.4 | 1.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.4 | 5.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.4 | 19.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.4 | 6.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.4 | 2.8 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
1.4 | 2.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
1.4 | 4.2 | GO:0070459 | prolactin secretion(GO:0070459) |
1.4 | 15.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.4 | 6.9 | GO:0009249 | protein lipoylation(GO:0009249) |
1.4 | 4.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.4 | 2.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.4 | 9.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.4 | 2.7 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.4 | 20.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.4 | 4.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.4 | 5.5 | GO:0046415 | urate metabolic process(GO:0046415) |
1.4 | 1.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.4 | 13.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
1.4 | 21.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.4 | 2.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.4 | 2.7 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
1.4 | 8.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.3 | 5.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
1.3 | 2.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.3 | 1.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.3 | 13.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.3 | 8.1 | GO:0006968 | cellular defense response(GO:0006968) |
1.3 | 16.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
1.3 | 2.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.3 | 6.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.3 | 2.7 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.3 | 4.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.3 | 4.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.3 | 1.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.3 | 1.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.3 | 1.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.3 | 1.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
1.3 | 6.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.3 | 3.9 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
1.3 | 22.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.3 | 3.9 | GO:0060068 | vagina development(GO:0060068) |
1.3 | 6.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.3 | 32.6 | GO:0043297 | apical junction assembly(GO:0043297) |
1.3 | 1.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
1.3 | 2.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.3 | 3.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.3 | 15.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.3 | 1.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.3 | 2.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.3 | 20.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
1.3 | 15.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.3 | 1.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
1.3 | 2.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.3 | 5.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
1.3 | 12.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.3 | 5.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.3 | 2.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.3 | 1.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.3 | 1.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
1.3 | 20.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.3 | 6.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.3 | 6.3 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.3 | 13.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.3 | 1.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
1.3 | 2.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.3 | 2.5 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
1.3 | 2.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.3 | 13.8 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
1.3 | 1.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
1.3 | 5.0 | GO:0071675 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
1.3 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.3 | 13.8 | GO:0071800 | podosome assembly(GO:0071800) |
1.3 | 2.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.2 | 3.7 | GO:0042363 | vitamin catabolic process(GO:0009111) terpenoid catabolic process(GO:0016115) fat-soluble vitamin catabolic process(GO:0042363) |
1.2 | 1.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.2 | 2.5 | GO:0002159 | desmosome assembly(GO:0002159) |
1.2 | 3.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.2 | 2.5 | GO:0031033 | myosin filament organization(GO:0031033) |
1.2 | 2.5 | GO:0048102 | autophagic cell death(GO:0048102) |
1.2 | 2.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.2 | 2.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.2 | 7.4 | GO:0051013 | microtubule severing(GO:0051013) |
1.2 | 1.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.2 | 7.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.2 | 3.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.2 | 6.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.2 | 4.9 | GO:0031639 | plasminogen activation(GO:0031639) |
1.2 | 34.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
1.2 | 6.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.2 | 2.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
1.2 | 6.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.2 | 6.1 | GO:0016559 | peroxisome fission(GO:0016559) |
1.2 | 21.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
1.2 | 3.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.2 | 4.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.2 | 10.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.2 | 7.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
1.2 | 9.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.2 | 3.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.2 | 4.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.2 | 1.2 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.2 | 7.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.2 | 28.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
1.2 | 9.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.2 | 3.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.2 | 8.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.2 | 2.4 | GO:0045730 | respiratory burst(GO:0045730) |
1.2 | 3.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.2 | 1.2 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
1.2 | 1.2 | GO:0001705 | ectoderm formation(GO:0001705) |
1.2 | 16.6 | GO:0006298 | mismatch repair(GO:0006298) |
1.2 | 5.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.2 | 8.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.2 | 1.2 | GO:0007398 | ectoderm development(GO:0007398) |
1.2 | 1.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
1.2 | 3.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.2 | 11.8 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
1.2 | 2.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
1.2 | 92.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
1.2 | 1.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.2 | 4.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
1.2 | 2.3 | GO:0070269 | pyroptosis(GO:0070269) |
1.2 | 10.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.2 | 25.6 | GO:0006414 | translational elongation(GO:0006414) |
1.2 | 1.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
1.2 | 3.5 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
1.2 | 18.6 | GO:0031648 | protein destabilization(GO:0031648) |
1.2 | 1.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
1.2 | 1.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.2 | 3.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.2 | 2.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.2 | 1.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
1.2 | 2.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.2 | 4.6 | GO:0016556 | mRNA modification(GO:0016556) |
1.1 | 2.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.1 | 8.0 | GO:0043248 | proteasome assembly(GO:0043248) |
1.1 | 1.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.1 | 1.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
1.1 | 12.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.1 | 60.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
1.1 | 8.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.1 | 4.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.1 | 2.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.1 | 41.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.1 | 16.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.1 | 12.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.1 | 2.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.1 | 10.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.1 | 6.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.1 | 3.4 | GO:0046909 | intermembrane transport(GO:0046909) |
1.1 | 3.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.1 | 2.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.1 | 14.6 | GO:0071467 | cellular response to pH(GO:0071467) |
1.1 | 2.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.1 | 5.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
1.1 | 1.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.1 | 5.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.1 | 8.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
1.1 | 16.7 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
1.1 | 2.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 1.1 | GO:0043476 | pigment accumulation(GO:0043476) |
1.1 | 1.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.1 | 1.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.1 | 5.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.1 | 11.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
1.1 | 2.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
1.1 | 3.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.1 | 3.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.1 | 2.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.1 | 38.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.1 | 11.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.1 | 2.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.1 | 4.4 | GO:0060242 | contact inhibition(GO:0060242) |
1.1 | 2.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 2.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
1.1 | 1.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.1 | 6.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.1 | 1.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.1 | 9.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.1 | 3.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.1 | 6.5 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
1.1 | 3.2 | GO:0015705 | iodide transport(GO:0015705) |
1.1 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
1.1 | 5.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.1 | 9.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.1 | 9.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
1.1 | 5.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 3.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.1 | 10.7 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.1 | 1.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.1 | 9.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
1.1 | 6.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.1 | 1.1 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
1.1 | 4.3 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
1.1 | 8.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
1.1 | 2.1 | GO:0051383 | kinetochore organization(GO:0051383) |
1.1 | 3.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
1.1 | 5.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.1 | 12.6 | GO:0051601 | exocyst localization(GO:0051601) |
1.1 | 2.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
1.0 | 1.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.0 | 1.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
1.0 | 1.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.0 | 4.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.0 | 15.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.0 | 3.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.0 | 18.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.0 | 1.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.0 | 5.2 | GO:0051451 | myoblast migration(GO:0051451) |
1.0 | 1.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.0 | 1.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.0 | 11.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
1.0 | 17.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.0 | 6.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
1.0 | 3.1 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
1.0 | 7.2 | GO:0046677 | response to antibiotic(GO:0046677) |
1.0 | 22.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.0 | 8.2 | GO:0070166 | enamel mineralization(GO:0070166) |
1.0 | 4.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.0 | 4.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.0 | 10.2 | GO:0048144 | fibroblast proliferation(GO:0048144) |
1.0 | 10.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.0 | 2.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.0 | 2.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.0 | 10.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.0 | 1.0 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
1.0 | 1.0 | GO:0009650 | UV protection(GO:0009650) |
1.0 | 4.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.0 | 2.0 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
1.0 | 2.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
1.0 | 1.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.0 | 11.0 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
1.0 | 1.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.0 | 5.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.0 | 42.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
1.0 | 12.8 | GO:0006491 | N-glycan processing(GO:0006491) |
1.0 | 2.9 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.0 | 1.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.0 | 2.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.0 | 1.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.0 | 1.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.0 | 1.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.0 | 53.5 | GO:0051028 | mRNA transport(GO:0051028) |
1.0 | 3.9 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.0 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
1.0 | 1.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.0 | 5.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.0 | 1.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.0 | 24.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
1.0 | 2.9 | GO:0051788 | response to misfolded protein(GO:0051788) |
1.0 | 16.4 | GO:0030261 | chromosome condensation(GO:0030261) |
1.0 | 1.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
1.0 | 23.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.0 | 1.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.0 | 6.7 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
1.0 | 2.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.0 | 1.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.0 | 3.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.0 | 1.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.9 | 0.9 | GO:0061055 | myotome development(GO:0061055) |
0.9 | 2.8 | GO:0042026 | protein refolding(GO:0042026) |
0.9 | 6.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.9 | 14.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.9 | 4.7 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.9 | 2.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.9 | 5.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.9 | 7.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.9 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
0.9 | 6.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.9 | 27.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.9 | 2.8 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.9 | 1.9 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.9 | 8.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.9 | 1.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.9 | 15.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.9 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.9 | 1.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 3.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.9 | 7.4 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.9 | 1.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 1.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.9 | 1.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.9 | 3.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.9 | 8.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.9 | 1.8 | GO:0051875 | pigment granule localization(GO:0051875) |
0.9 | 3.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.9 | 2.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.9 | 4.5 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.9 | 0.9 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.9 | 0.9 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.9 | 6.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.9 | 21.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.9 | 1.8 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.9 | 26.2 | GO:0042073 | intraciliary transport(GO:0042073) |
0.9 | 1.8 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.9 | 1.8 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.9 | 5.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.9 | 2.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.9 | 2.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.9 | 0.9 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.9 | 2.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.9 | 8.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.9 | 0.9 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.9 | 0.9 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.9 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.9 | 8.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.9 | 1.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.9 | 0.9 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.9 | 5.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.9 | 3.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.9 | 3.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.9 | 4.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.9 | 10.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.9 | 0.9 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.9 | 0.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.9 | 2.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.9 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.9 | 6.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.9 | 1.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.9 | 0.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.9 | 2.6 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.9 | 1.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.9 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.9 | 1.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.9 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.9 | 3.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.9 | 8.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.9 | 0.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.9 | 38.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.9 | 0.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.9 | 4.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.9 | 1.7 | GO:0070268 | cornification(GO:0070268) |
0.9 | 0.9 | GO:0001893 | maternal placenta development(GO:0001893) |
0.9 | 1.7 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.9 | 6.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.8 | 5.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.8 | 8.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.8 | 5.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.8 | 8.4 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.8 | 10.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.8 | 3.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.8 | 0.8 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.8 | 12.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.8 | 2.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.8 | 2.5 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 4.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.8 | 0.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 2.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.8 | 3.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.8 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.8 | 1.7 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.8 | 6.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.8 | 0.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.8 | 2.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.8 | 4.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.8 | 8.2 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.8 | 1.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.8 | 1.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 4.0 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.8 | 0.8 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.8 | 0.8 | GO:0019042 | viral latency(GO:0019042) |
0.8 | 1.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.8 | 6.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.8 | 4.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.8 | 4.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.8 | 11.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 3.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.8 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 0.8 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.8 | 1.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.8 | 4.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.8 | 10.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.8 | 1.6 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.8 | 3.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.8 | 0.8 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.8 | 0.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.8 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.8 | 3.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.8 | 7.7 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.8 | 2.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.8 | 3.8 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.8 | 6.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.8 | 0.8 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.8 | 19.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 5.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.8 | 24.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.8 | 0.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.8 | 2.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.8 | 5.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.8 | 9.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.8 | 0.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.8 | 3.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.7 | 3.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.7 | 2.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.7 | 1.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.7 | 0.7 | GO:0043307 | eosinophil activation(GO:0043307) |
0.7 | 1.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.7 | 0.7 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.7 | 4.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 0.7 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.7 | 2.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.7 | 2.9 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.7 | 0.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.7 | 8.8 | GO:0030104 | water homeostasis(GO:0030104) |
0.7 | 0.7 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.7 | 0.7 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.7 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.7 | 6.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.7 | 1.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.7 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 1.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 2.9 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.7 | 1.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.7 | 2.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.7 | 2.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.7 | 0.7 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.7 | 1.4 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.7 | 2.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.7 | 0.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.7 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 1.4 | GO:0009838 | abscission(GO:0009838) |
0.7 | 1.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.7 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.7 | 1.4 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.7 | 0.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.7 | 2.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.7 | 1.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.7 | 5.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.7 | 7.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 13.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.7 | 6.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.7 | 3.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.7 | 19.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.7 | 13.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.7 | 0.7 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.7 | 7.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.7 | 2.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.7 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 1.4 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 0.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.7 | 2.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.7 | 1.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.7 | 3.4 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.7 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.7 | 0.7 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.7 | 2.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.7 | 4.0 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.7 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 3.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 1.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.7 | 2.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 1.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.7 | 2.0 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.7 | 7.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 2.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.7 | 7.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.7 | 0.7 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.7 | 2.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.7 | 2.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.7 | 1.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.7 | 1.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.6 | 5.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.6 | 5.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.6 | 5.8 | GO:0043489 | RNA stabilization(GO:0043489) |
0.6 | 2.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.6 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 4.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 2.6 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.6 | 0.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.6 | 2.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.6 | 1.9 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.6 | 1.3 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.6 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.6 | 1.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.6 | 0.6 | GO:0051299 | centrosome separation(GO:0051299) |
0.6 | 3.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.6 | 2.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 1.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.6 | 8.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.6 | 0.6 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.6 | 5.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.6 | 1.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.6 | 4.4 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.6 | 7.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.6 | 0.6 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.6 | 1.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.6 | 0.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.6 | 1.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 1.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.6 | 4.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.6 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 11.0 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.6 | 0.6 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.6 | 0.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.6 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.6 | 4.2 | GO:0048535 | lymph node development(GO:0048535) |
0.6 | 0.6 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.6 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 3.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 1.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 1.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.6 | 3.0 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.6 | 0.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.6 | 10.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.6 | 2.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 0.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.6 | 3.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.6 | 0.6 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.6 | 1.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 2.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.6 | 1.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.6 | 2.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.6 | 15.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.6 | 7.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.6 | 2.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 4.6 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.6 | 0.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 9.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.6 | 5.8 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.6 | 2.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.6 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.6 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 14.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.6 | 2.8 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.6 | 3.4 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.6 | 11.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.6 | 5.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.6 | 1.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 6.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.6 | 3.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.6 | 0.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.6 | 2.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.6 | 3.3 | GO:0051904 | pigment granule transport(GO:0051904) |
0.6 | 6.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.6 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.6 | 6.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.6 | 0.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 4.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.5 | 1.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 1.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 0.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.5 | 1.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 4.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.5 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 1.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 0.5 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.5 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.5 | 6.4 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.5 | 1.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.5 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.5 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 1.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 3.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.5 | 1.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.5 | 2.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.5 | 0.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.5 | 8.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.5 | 3.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 3.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 0.5 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.5 | 1.5 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.5 | 23.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.5 | 6.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.5 | 1.5 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.5 | 5.1 | GO:0007032 | endosome organization(GO:0007032) |
0.5 | 26.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.5 | 1.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.5 | 1.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 1.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.5 | 0.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.5 | 2.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 0.5 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.5 | 1.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.5 | 11.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.5 | 4.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 0.5 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.5 | 3.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 20.7 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.5 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 1.0 | GO:0070542 | response to fatty acid(GO:0070542) |
0.5 | 15.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.5 | 3.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 1.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.5 | 1.5 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 0.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.5 | 16.4 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.5 | 8.7 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.5 | 1.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.5 | 2.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 3.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 1.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.5 | 1.4 | GO:0002784 | positive regulation of antimicrobial peptide production(GO:0002225) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 1.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 | 1.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 23.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.5 | 0.5 | GO:0045851 | pH reduction(GO:0045851) |
0.5 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.5 | 0.5 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.5 | 0.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.5 | 28.0 | GO:0050817 | coagulation(GO:0050817) |
0.5 | 3.7 | GO:0032438 | melanosome organization(GO:0032438) |
0.5 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 0.9 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.5 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 0.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 1.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 2.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 2.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.4 | 13.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 0.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.4 | 3.9 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.4 | 1.7 | GO:0034505 | tooth mineralization(GO:0034505) |
0.4 | 0.9 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 3.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 49.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.4 | 0.4 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 3.4 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.4 | 1.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 0.8 | GO:0007127 | meiosis I(GO:0007127) |
0.4 | 9.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.4 | 3.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 6.2 | GO:0007602 | phototransduction(GO:0007602) |
0.4 | 4.5 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 0.8 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 3.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 1.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 1.6 | GO:0007098 | centrosome cycle(GO:0007098) |
0.4 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 1.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.4 | 1.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 0.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 3.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.4 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.4 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 0.4 | GO:0060416 | response to growth hormone(GO:0060416) |
0.4 | 0.8 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.4 | 1.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.4 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.4 | 0.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.4 | 1.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 0.8 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.4 | 0.8 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.4 | 4.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 2.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 1.5 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.4 | 2.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 5.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.4 | 2.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.4 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 1.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.4 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 1.1 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.4 | 0.7 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 0.7 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.4 | 3.9 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 5.2 | GO:0031929 | TOR signaling(GO:0031929) |
0.3 | 1.7 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 2.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 1.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 3.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 2.4 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.3 | 0.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.3 | 1.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 2.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 1.0 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.3 | 0.3 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.3 | 1.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 1.3 | GO:0006956 | complement activation(GO:0006956) |
0.3 | 0.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.3 | 3.0 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.3 | 0.3 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 22.8 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.3 | 8.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 1.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 2.0 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 1.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 2.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.3 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 0.6 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.3 | 0.6 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.3 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.3 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.3 | 0.3 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.3 | 0.6 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 6.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.3 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 5.8 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.3 | 2.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 2.7 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.3 | 1.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.3 | 1.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 0.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.3 | 0.9 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 1.5 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.3 | 0.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.3 | 2.7 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 0.6 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.3 | 4.1 | GO:0036503 | ERAD pathway(GO:0036503) |
0.3 | 10.9 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 0.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 0.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 0.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.6 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.3 | 0.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.3 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 1.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.3 | 2.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 3.9 | GO:1990266 | neutrophil migration(GO:1990266) |
0.3 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.3 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.2 | 3.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 3.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 21.0 | GO:0006396 | RNA processing(GO:0006396) |
0.2 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.2 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 4.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 13.4 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.2 | 15.9 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.2 | 0.2 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.2 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 1.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 3.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.7 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 0.2 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.2 | 0.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.2 | 5.4 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.2 | 1.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.2 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.2 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.6 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.2 | 1.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 15.9 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.2 | 1.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.2 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.2 | 1.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.8 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.2 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.2 | 8.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 1.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.1 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.1 | 5.7 | GO:0009617 | response to bacterium(GO:0009617) |
0.1 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 14.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 4.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.1 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 0.8 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.1 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.1 | 0.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) positive regulation of interleukin-13 production(GO:0032736) |
0.1 | 1.0 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.9 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.7 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.5 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 3.8 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.3 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 2.7 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.6 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 6.9 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 19.3 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.9 | 64.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
9.1 | 45.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
7.7 | 38.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
7.4 | 22.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
6.9 | 34.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
6.4 | 19.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
6.0 | 35.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
5.6 | 16.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
5.3 | 31.8 | GO:1990462 | omegasome(GO:1990462) |
5.1 | 10.2 | GO:0032010 | phagolysosome(GO:0032010) |
4.8 | 19.2 | GO:1990130 | Iml1 complex(GO:1990130) |
4.8 | 23.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.7 | 23.4 | GO:0005638 | lamin filament(GO:0005638) |
4.5 | 49.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
4.4 | 26.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.4 | 34.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
4.3 | 12.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
4.3 | 17.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
4.2 | 4.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
4.2 | 12.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
4.2 | 16.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.1 | 16.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
4.1 | 12.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
4.0 | 12.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
4.0 | 11.9 | GO:0097443 | sorting endosome(GO:0097443) |
3.9 | 27.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.8 | 15.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
3.8 | 15.1 | GO:0042825 | TAP complex(GO:0042825) |
3.7 | 11.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.7 | 11.2 | GO:0000811 | GINS complex(GO:0000811) |
3.7 | 18.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.6 | 25.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.6 | 24.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.6 | 10.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
3.5 | 35.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
3.5 | 17.7 | GO:0030056 | hemidesmosome(GO:0030056) |
3.5 | 14.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
3.5 | 14.0 | GO:0033269 | internode region of axon(GO:0033269) |
3.5 | 10.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.5 | 90.5 | GO:0008305 | integrin complex(GO:0008305) |
3.5 | 45.2 | GO:0031528 | microvillus membrane(GO:0031528) |
3.5 | 24.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
3.3 | 3.3 | GO:0031523 | Myb complex(GO:0031523) |
3.3 | 9.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.3 | 22.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
3.2 | 22.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
3.2 | 45.3 | GO:0001891 | phagocytic cup(GO:0001891) |
3.2 | 25.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
3.2 | 25.8 | GO:0043203 | axon hillock(GO:0043203) |
3.2 | 16.0 | GO:0061617 | MICOS complex(GO:0061617) |
3.1 | 12.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.1 | 3.1 | GO:0005914 | spot adherens junction(GO:0005914) |
3.1 | 9.3 | GO:0097413 | Lewy body(GO:0097413) |
3.1 | 9.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
3.1 | 24.5 | GO:0005861 | troponin complex(GO:0005861) |
3.0 | 9.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
3.0 | 24.2 | GO:0070652 | HAUS complex(GO:0070652) |
3.0 | 11.9 | GO:0072487 | MSL complex(GO:0072487) |
3.0 | 5.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.9 | 8.8 | GO:0005745 | m-AAA complex(GO:0005745) |
2.9 | 20.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
2.9 | 8.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.9 | 11.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.9 | 17.4 | GO:0042629 | mast cell granule(GO:0042629) |
2.8 | 22.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.8 | 168.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.8 | 8.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.8 | 19.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.8 | 8.3 | GO:1990423 | RZZ complex(GO:1990423) |
2.8 | 16.5 | GO:0042599 | lamellar body(GO:0042599) |
2.7 | 5.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.7 | 43.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.7 | 21.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.6 | 13.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.6 | 7.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.6 | 5.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
2.6 | 7.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.6 | 7.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.6 | 12.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.6 | 25.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.6 | 17.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
2.5 | 17.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
2.5 | 10.1 | GO:0005642 | annulate lamellae(GO:0005642) |
2.5 | 17.5 | GO:0031931 | TORC1 complex(GO:0031931) |
2.5 | 19.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
2.5 | 12.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.5 | 17.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 4.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.4 | 107.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.4 | 24.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.4 | 16.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.4 | 7.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.4 | 9.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.4 | 73.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.4 | 4.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.4 | 11.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.4 | 33.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.3 | 7.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.3 | 16.4 | GO:0001650 | fibrillar center(GO:0001650) |
2.3 | 97.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
2.3 | 11.6 | GO:0097422 | tubular endosome(GO:0097422) |
2.3 | 66.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.3 | 6.9 | GO:0005712 | chiasma(GO:0005712) |
2.3 | 9.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.3 | 9.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
2.3 | 6.8 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.3 | 22.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
2.3 | 6.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.3 | 24.8 | GO:0032039 | integrator complex(GO:0032039) |
2.2 | 29.1 | GO:0030914 | STAGA complex(GO:0030914) |
2.2 | 19.7 | GO:0002102 | podosome(GO:0002102) |
2.2 | 188.2 | GO:0072562 | blood microparticle(GO:0072562) |
2.2 | 10.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.2 | 8.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
2.2 | 21.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.1 | 23.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
2.1 | 4.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.1 | 12.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
2.1 | 12.8 | GO:0045179 | apical cortex(GO:0045179) |
2.1 | 2.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.1 | 132.8 | GO:0042641 | actomyosin(GO:0042641) |
2.1 | 8.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
2.1 | 35.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
2.1 | 14.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.1 | 55.7 | GO:0031901 | early endosome membrane(GO:0031901) |
2.1 | 12.3 | GO:0001739 | sex chromatin(GO:0001739) |
2.0 | 6.1 | GO:0097452 | GAIT complex(GO:0097452) |
2.0 | 6.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
2.0 | 18.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.0 | 6.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
2.0 | 8.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.0 | 8.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.0 | 10.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.0 | 12.0 | GO:0042587 | glycogen granule(GO:0042587) |
2.0 | 8.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
2.0 | 11.8 | GO:0031932 | TORC2 complex(GO:0031932) |
2.0 | 17.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.0 | 7.8 | GO:0033263 | CORVET complex(GO:0033263) |
1.9 | 1.9 | GO:0070545 | PeBoW complex(GO:0070545) |
1.9 | 23.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.9 | 5.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.9 | 5.7 | GO:0031417 | NatC complex(GO:0031417) |
1.9 | 13.2 | GO:0042382 | paraspeckles(GO:0042382) |
1.8 | 49.7 | GO:0015030 | Cajal body(GO:0015030) |
1.8 | 1.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.8 | 14.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.8 | 16.3 | GO:0031430 | M band(GO:0031430) |
1.8 | 9.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.8 | 14.4 | GO:0070938 | contractile ring(GO:0070938) |
1.8 | 3.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.8 | 3.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.8 | 10.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.8 | 3.6 | GO:0008091 | spectrin(GO:0008091) |
1.8 | 7.1 | GO:0098536 | deuterosome(GO:0098536) |
1.7 | 5.2 | GO:1990923 | PET complex(GO:1990923) |
1.7 | 3.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.7 | 5.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.7 | 29.5 | GO:0031672 | A band(GO:0031672) |
1.7 | 25.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.7 | 6.9 | GO:0044194 | cytolytic granule(GO:0044194) |
1.7 | 90.5 | GO:0005811 | lipid particle(GO:0005811) |
1.7 | 1.7 | GO:0044327 | dendritic spine head(GO:0044327) |
1.7 | 8.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.7 | 8.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.7 | 3.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.7 | 21.8 | GO:0000786 | nucleosome(GO:0000786) |
1.7 | 10.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.7 | 3.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.7 | 10.0 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.7 | 15.0 | GO:0031143 | pseudopodium(GO:0031143) |
1.7 | 18.3 | GO:0042581 | specific granule(GO:0042581) |
1.7 | 5.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.6 | 27.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.6 | 6.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.6 | 8.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.6 | 16.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.6 | 1.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
1.6 | 6.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.6 | 38.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
1.6 | 11.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.6 | 28.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.6 | 71.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.6 | 6.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.6 | 7.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.6 | 10.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.5 | 6.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.5 | 38.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.5 | 3.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.5 | 19.9 | GO:0036038 | MKS complex(GO:0036038) |
1.5 | 9.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.5 | 22.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.5 | 1.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.5 | 10.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.5 | 4.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.5 | 6.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.5 | 19.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.5 | 23.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.5 | 4.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 17.6 | GO:0043196 | varicosity(GO:0043196) |
1.5 | 4.4 | GO:0042827 | platelet dense granule(GO:0042827) |
1.5 | 22.0 | GO:0001772 | immunological synapse(GO:0001772) |
1.5 | 2.9 | GO:0000805 | X chromosome(GO:0000805) |
1.5 | 1.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.5 | 30.6 | GO:0005771 | multivesicular body(GO:0005771) |
1.4 | 1.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.4 | 11.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.4 | 7.2 | GO:0005827 | polar microtubule(GO:0005827) |
1.4 | 4.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.4 | 7.1 | GO:0030870 | Mre11 complex(GO:0030870) |
1.4 | 34.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.4 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.4 | 8.5 | GO:0034709 | methylosome(GO:0034709) |
1.4 | 9.9 | GO:0030008 | TRAPP complex(GO:0030008) |
1.4 | 13.9 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
1.4 | 5.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
1.4 | 11.1 | GO:0005869 | dynactin complex(GO:0005869) |
1.4 | 22.1 | GO:0005682 | U5 snRNP(GO:0005682) |
1.4 | 11.0 | GO:0010369 | chromocenter(GO:0010369) |
1.4 | 6.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.4 | 4.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.4 | 5.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.4 | 27.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.4 | 12.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.4 | 9.5 | GO:0071010 | prespliceosome(GO:0071010) |
1.3 | 51.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.3 | 12.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.3 | 9.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.3 | 12.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.3 | 4.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.3 | 13.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.3 | 9.3 | GO:0097470 | ribbon synapse(GO:0097470) |
1.3 | 4.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.3 | 27.8 | GO:0097228 | sperm principal piece(GO:0097228) |
1.3 | 42.3 | GO:0016592 | mediator complex(GO:0016592) |
1.3 | 2.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.3 | 80.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.3 | 18.4 | GO:0045120 | pronucleus(GO:0045120) |
1.3 | 47.1 | GO:0030118 | clathrin coat(GO:0030118) |
1.3 | 10.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
1.3 | 3.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.3 | 15.5 | GO:0043034 | costamere(GO:0043034) |
1.3 | 9.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.3 | 172.5 | GO:0005938 | cell cortex(GO:0005938) |
1.3 | 11.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.3 | 18.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.3 | 3.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.3 | 18.0 | GO:0000242 | pericentriolar material(GO:0000242) |
1.3 | 2.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.3 | 12.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.3 | 55.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
1.3 | 3.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.3 | 49.7 | GO:0000776 | kinetochore(GO:0000776) |
1.3 | 26.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.3 | 20.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.3 | 3.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.3 | 7.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.2 | 16.2 | GO:0042588 | zymogen granule(GO:0042588) |
1.2 | 9.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.2 | 158.7 | GO:0000139 | Golgi membrane(GO:0000139) |
1.2 | 29.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.2 | 57.9 | GO:0000922 | spindle pole(GO:0000922) |
1.2 | 8.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.2 | 8.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.2 | 3.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.2 | 10.8 | GO:0005795 | Golgi stack(GO:0005795) |
1.2 | 5.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.2 | 3.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.2 | 1.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.2 | 48.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.2 | 50.7 | GO:0016605 | PML body(GO:0016605) |
1.2 | 4.7 | GO:0000938 | GARP complex(GO:0000938) |
1.2 | 37.7 | GO:0005844 | polysome(GO:0005844) |
1.2 | 23.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.2 | 3.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.2 | 19.7 | GO:0010008 | endosome membrane(GO:0010008) |
1.2 | 3.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.1 | 64.3 | GO:0000502 | proteasome complex(GO:0000502) |
1.1 | 41.3 | GO:0005643 | nuclear pore(GO:0005643) |
1.1 | 80.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.1 | 5.6 | GO:0035861 | site of double-strand break(GO:0035861) |
1.1 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.1 | 1.1 | GO:0032432 | actin filament bundle(GO:0032432) |
1.1 | 8.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.1 | 13.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.1 | 9.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
1.1 | 2.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
1.1 | 2.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.1 | 213.9 | GO:0005925 | focal adhesion(GO:0005925) |
1.1 | 24.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.1 | 4.3 | GO:0031970 | nuclear envelope lumen(GO:0005641) organelle envelope lumen(GO:0031970) |
1.1 | 10.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.1 | 78.6 | GO:0005581 | collagen trimer(GO:0005581) |
1.1 | 6.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
1.1 | 9.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.1 | 4.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.1 | 43.1 | GO:0016363 | nuclear matrix(GO:0016363) |
1.1 | 7.4 | GO:0005686 | U2 snRNP(GO:0005686) |
1.0 | 3.1 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.0 | 22.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.0 | 6.2 | GO:0034464 | BBSome(GO:0034464) |
1.0 | 15.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.0 | 3.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.0 | 20.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.0 | 80.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.0 | 11.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.0 | 35.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.0 | 4.1 | GO:0035339 | SPOTS complex(GO:0035339) |
1.0 | 3.0 | GO:0043293 | apoptosome(GO:0043293) |
1.0 | 15.1 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 8.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.0 | 11.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.0 | 7.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.0 | 2.0 | GO:0070069 | cytochrome complex(GO:0070069) |
1.0 | 3.9 | GO:0044815 | DNA packaging complex(GO:0044815) |
1.0 | 2.9 | GO:0008278 | cohesin complex(GO:0008278) |
1.0 | 1.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.0 | 9.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.0 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 0.9 | GO:0045178 | basal part of cell(GO:0045178) |
0.9 | 16.9 | GO:0005776 | autophagosome(GO:0005776) |
0.9 | 7.4 | GO:0005657 | replication fork(GO:0005657) |
0.9 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 2.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.9 | 21.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.9 | 255.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.9 | 4.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.9 | 32.4 | GO:0030496 | midbody(GO:0030496) |
0.9 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.9 | 1.8 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.9 | 2.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.9 | 2.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.9 | 2.7 | GO:0090543 | Flemming body(GO:0090543) |
0.9 | 4.4 | GO:0071546 | pi-body(GO:0071546) |
0.9 | 27.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.9 | 1.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.9 | 2.6 | GO:0001652 | granular component(GO:0001652) |
0.9 | 2.6 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 2.6 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 241.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 1.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.9 | 0.9 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.9 | 45.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.8 | 2.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 38.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.8 | 5.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.8 | 23.5 | GO:0005902 | microvillus(GO:0005902) |
0.8 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 3.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 16.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.8 | 12.3 | GO:0000785 | chromatin(GO:0000785) |
0.8 | 7.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.8 | 3.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.8 | 15.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.8 | 2.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.8 | 833.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.8 | 3.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 2.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.8 | 21.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.8 | 7.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.8 | 28.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.8 | 49.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.8 | 84.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 8.4 | GO:0030684 | preribosome(GO:0030684) |
0.8 | 2.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 45.0 | GO:0005903 | brush border(GO:0005903) |
0.7 | 10.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.7 | 20.1 | GO:0005901 | caveola(GO:0005901) |
0.7 | 1.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.7 | 6.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.7 | 2.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 43.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.7 | 59.0 | GO:0005694 | chromosome(GO:0005694) |
0.7 | 6.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 25.6 | GO:0016528 | sarcoplasm(GO:0016528) |
0.7 | 2.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 2.1 | GO:0042627 | chylomicron(GO:0042627) |
0.7 | 17.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.7 | 6.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 6.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.7 | 2.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.7 | 6.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 472.1 | GO:0005829 | cytosol(GO:0005829) |
0.6 | 20.5 | GO:0045095 | keratin filament(GO:0045095) |
0.6 | 79.1 | GO:0005813 | centrosome(GO:0005813) |
0.6 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 2.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.6 | 358.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.6 | 1.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.6 | 2.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.6 | 2.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 1.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 99.9 | GO:0005730 | nucleolus(GO:0005730) |
0.5 | 1.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 8.6 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 1.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.5 | 486.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.5 | 1.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 5.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 6.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.4 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 54.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 0.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 1.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 1.0 | GO:0005770 | late endosome(GO:0005770) |
0.3 | 5.5 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 175.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 5.4 | GO:0031514 | motile cilium(GO:0031514) |
0.3 | 4.2 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 9.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.4 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 5.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 13.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 4.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 4.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.1 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.1 | 0.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 162.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.3 | 72.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
10.3 | 41.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
9.7 | 38.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
9.2 | 27.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
8.9 | 26.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
8.7 | 8.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
8.7 | 60.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
8.4 | 33.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
8.2 | 32.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
7.9 | 23.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
7.9 | 23.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
7.9 | 31.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
7.7 | 23.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
7.6 | 22.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
7.5 | 22.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
7.2 | 21.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
7.1 | 28.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
6.7 | 26.9 | GO:0015265 | urea channel activity(GO:0015265) |
6.3 | 31.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
6.1 | 24.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
6.0 | 30.0 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
6.0 | 12.0 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
6.0 | 17.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
5.9 | 23.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
5.7 | 17.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
5.4 | 21.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
5.4 | 16.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
5.4 | 16.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.3 | 37.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
5.3 | 15.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
5.2 | 25.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
5.1 | 20.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
5.1 | 5.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
5.0 | 10.1 | GO:0030172 | troponin C binding(GO:0030172) |
5.0 | 15.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
5.0 | 24.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
5.0 | 14.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
5.0 | 14.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
4.8 | 14.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
4.8 | 19.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
4.8 | 9.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
4.7 | 18.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
4.7 | 18.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
4.7 | 23.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
4.7 | 18.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
4.7 | 14.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
4.7 | 28.0 | GO:0016936 | galactoside binding(GO:0016936) |
4.7 | 14.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.6 | 4.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
4.6 | 27.3 | GO:0008199 | ferric iron binding(GO:0008199) |
4.5 | 31.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
4.5 | 4.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
4.5 | 22.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
4.5 | 102.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
4.4 | 13.2 | GO:0004064 | arylesterase activity(GO:0004064) |
4.4 | 13.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
4.4 | 13.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
4.3 | 30.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
4.3 | 12.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
4.3 | 12.9 | GO:0019961 | interferon binding(GO:0019961) |
4.3 | 34.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
4.2 | 12.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
4.2 | 12.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
4.2 | 4.2 | GO:0070538 | oleic acid binding(GO:0070538) |
4.2 | 33.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
4.2 | 24.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
4.1 | 8.3 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
4.1 | 12.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
4.0 | 12.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
4.0 | 12.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
4.0 | 16.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
4.0 | 16.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.0 | 4.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
4.0 | 12.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
4.0 | 11.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
4.0 | 11.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.9 | 23.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
3.8 | 11.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.8 | 11.4 | GO:0031014 | troponin T binding(GO:0031014) |
3.8 | 11.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
3.8 | 34.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
3.8 | 7.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
3.8 | 18.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.7 | 7.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
3.7 | 29.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
3.7 | 11.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.6 | 72.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.6 | 14.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
3.6 | 43.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
3.6 | 3.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
3.6 | 28.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.6 | 10.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
3.6 | 17.8 | GO:0070061 | fructose binding(GO:0070061) |
3.6 | 28.4 | GO:0008430 | selenium binding(GO:0008430) |
3.5 | 21.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.5 | 14.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.5 | 28.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
3.5 | 31.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
3.5 | 14.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
3.5 | 14.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.5 | 20.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
3.5 | 10.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
3.5 | 10.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.5 | 41.6 | GO:0017166 | vinculin binding(GO:0017166) |
3.5 | 13.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
3.5 | 10.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.4 | 10.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.4 | 10.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
3.4 | 10.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
3.4 | 13.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
3.3 | 10.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
3.3 | 13.3 | GO:0051425 | PTB domain binding(GO:0051425) |
3.3 | 9.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
3.3 | 9.9 | GO:2001069 | glycogen binding(GO:2001069) |
3.3 | 16.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.3 | 9.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
3.3 | 13.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
3.2 | 9.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
3.2 | 3.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
3.2 | 9.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
3.2 | 9.6 | GO:0080084 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
3.2 | 9.6 | GO:0050692 | DBD domain binding(GO:0050692) |
3.2 | 16.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.2 | 6.4 | GO:0035877 | death effector domain binding(GO:0035877) |
3.2 | 9.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
3.2 | 41.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
3.2 | 25.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.1 | 9.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
3.1 | 9.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
3.1 | 18.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.1 | 15.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
3.1 | 18.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
3.1 | 18.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
3.1 | 9.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
3.0 | 18.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.0 | 12.1 | GO:0015232 | heme transporter activity(GO:0015232) |
3.0 | 12.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
3.0 | 6.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
3.0 | 15.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.9 | 8.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.9 | 11.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.9 | 29.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
2.9 | 11.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.9 | 2.9 | GO:0004096 | catalase activity(GO:0004096) |
2.9 | 51.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
2.9 | 8.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.9 | 20.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
2.9 | 11.5 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.9 | 8.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.8 | 17.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
2.8 | 17.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.8 | 61.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.8 | 11.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.8 | 25.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.8 | 11.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.8 | 16.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
2.8 | 11.1 | GO:0009374 | biotin binding(GO:0009374) |
2.8 | 5.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.8 | 8.3 | GO:0048030 | disaccharide binding(GO:0048030) |
2.7 | 24.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
2.7 | 16.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.7 | 48.9 | GO:0001848 | complement binding(GO:0001848) |
2.7 | 8.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.7 | 5.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.7 | 8.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.7 | 8.0 | GO:0030984 | kininogen binding(GO:0030984) |
2.7 | 8.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.7 | 24.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.7 | 8.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
2.7 | 10.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.7 | 8.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.7 | 13.3 | GO:0046790 | virion binding(GO:0046790) |
2.7 | 21.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.7 | 8.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.6 | 10.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
2.6 | 13.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.6 | 5.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.6 | 76.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.6 | 34.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
2.6 | 31.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
2.6 | 23.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.6 | 7.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.6 | 36.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.6 | 10.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
2.5 | 7.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.5 | 35.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.5 | 5.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.5 | 12.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
2.5 | 17.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.5 | 9.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.5 | 2.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
2.5 | 7.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.5 | 9.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.5 | 14.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.4 | 2.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
2.4 | 12.2 | GO:0043559 | insulin binding(GO:0043559) |
2.4 | 4.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.4 | 2.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
2.4 | 16.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.4 | 7.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.4 | 7.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
2.4 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.4 | 9.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.4 | 7.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.4 | 2.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
2.4 | 18.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.3 | 7.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.3 | 4.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
2.3 | 16.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.3 | 7.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.3 | 41.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.3 | 9.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
2.3 | 2.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
2.3 | 6.9 | GO:0043199 | sulfate binding(GO:0043199) |
2.3 | 20.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.3 | 11.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.3 | 18.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
2.3 | 4.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.3 | 9.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.3 | 9.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.3 | 18.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.3 | 63.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.3 | 6.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.3 | 20.3 | GO:0034522 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
2.2 | 4.5 | GO:0005119 | smoothened binding(GO:0005119) |
2.2 | 2.2 | GO:0045340 | mercury ion binding(GO:0045340) |
2.2 | 20.0 | GO:0031996 | thioesterase binding(GO:0031996) |
2.2 | 22.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.2 | 101.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
2.2 | 15.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
2.2 | 15.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
2.2 | 8.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.2 | 19.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.2 | 4.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
2.2 | 6.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.2 | 8.6 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.2 | 2.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.1 | 15.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.1 | 17.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.1 | 6.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
2.1 | 8.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.1 | 8.5 | GO:0043515 | kinetochore binding(GO:0043515) |
2.1 | 40.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.1 | 65.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
2.1 | 19.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
2.1 | 19.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.1 | 8.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.1 | 10.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.1 | 6.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.1 | 10.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
2.1 | 22.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
2.1 | 6.2 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
2.0 | 6.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.0 | 2.0 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
2.0 | 8.1 | GO:0042731 | PH domain binding(GO:0042731) |
2.0 | 2.0 | GO:0050693 | LBD domain binding(GO:0050693) |
2.0 | 8.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
2.0 | 8.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.0 | 8.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
2.0 | 8.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
2.0 | 24.1 | GO:0019825 | oxygen binding(GO:0019825) |
2.0 | 12.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.0 | 25.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
2.0 | 5.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.0 | 5.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.0 | 5.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
2.0 | 47.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
2.0 | 19.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.9 | 21.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.9 | 17.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.9 | 7.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.9 | 19.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.9 | 3.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.9 | 9.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.9 | 5.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.9 | 3.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.9 | 3.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.9 | 3.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.9 | 3.8 | GO:0030519 | snoRNP binding(GO:0030519) |
1.9 | 9.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.9 | 18.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.9 | 24.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.9 | 22.4 | GO:0008143 | poly(A) binding(GO:0008143) |
1.9 | 1.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.9 | 39.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.9 | 14.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.9 | 7.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.9 | 5.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.9 | 7.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.8 | 7.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.8 | 103.0 | GO:0002039 | p53 binding(GO:0002039) |
1.8 | 9.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.8 | 12.8 | GO:0050700 | CARD domain binding(GO:0050700) |
1.8 | 11.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.8 | 7.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.8 | 32.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.8 | 1.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.8 | 5.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.8 | 1.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.8 | 9.0 | GO:0015288 | porin activity(GO:0015288) |
1.8 | 12.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.8 | 55.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.8 | 14.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.8 | 5.4 | GO:0035197 | siRNA binding(GO:0035197) |
1.8 | 5.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.8 | 7.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.8 | 5.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.8 | 14.2 | GO:0015266 | protein channel activity(GO:0015266) |
1.8 | 3.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.8 | 24.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.8 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.8 | 1.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.8 | 5.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.8 | 7.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.7 | 13.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.7 | 3.5 | GO:0034618 | arginine binding(GO:0034618) |
1.7 | 48.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.7 | 1.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.7 | 5.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.7 | 12.0 | GO:0018634 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.7 | 1.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
1.7 | 30.7 | GO:0045502 | dynein binding(GO:0045502) |
1.7 | 5.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.7 | 10.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.7 | 5.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.7 | 11.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.7 | 3.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.7 | 10.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.7 | 3.4 | GO:0038100 | nodal binding(GO:0038100) |
1.7 | 6.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.7 | 8.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.7 | 5.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.7 | 15.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.7 | 15.1 | GO:0010181 | FMN binding(GO:0010181) |
1.7 | 8.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.7 | 11.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.7 | 6.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.6 | 4.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.6 | 24.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.6 | 44.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.6 | 4.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.6 | 4.9 | GO:0032052 | bile acid binding(GO:0032052) |
1.6 | 1.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.6 | 6.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.6 | 41.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.6 | 3.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.6 | 12.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.6 | 11.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.6 | 17.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.6 | 7.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.6 | 150.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.6 | 39.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.6 | 1.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.6 | 6.3 | GO:0005113 | patched binding(GO:0005113) |
1.6 | 4.7 | GO:0043426 | MRF binding(GO:0043426) |
1.6 | 45.6 | GO:0030145 | manganese ion binding(GO:0030145) |
1.6 | 17.3 | GO:0001618 | virus receptor activity(GO:0001618) |
1.6 | 36.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.6 | 7.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.6 | 6.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.6 | 7.8 | GO:0008494 | translation activator activity(GO:0008494) |
1.6 | 21.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.5 | 4.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.5 | 1.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.5 | 3.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.5 | 9.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.5 | 6.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.5 | 24.4 | GO:0008483 | transaminase activity(GO:0008483) |
1.5 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.5 | 27.4 | GO:0030515 | snoRNA binding(GO:0030515) |
1.5 | 19.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.5 | 10.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.5 | 7.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.5 | 9.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.5 | 40.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.5 | 1.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 4.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.5 | 7.4 | GO:0005536 | glucose binding(GO:0005536) |
1.5 | 5.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.5 | 39.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.5 | 38.0 | GO:0015485 | cholesterol binding(GO:0015485) |
1.5 | 8.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.5 | 8.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.5 | 7.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.5 | 24.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.4 | 4.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.4 | 5.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 14.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.4 | 1.4 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
1.4 | 20.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.4 | 11.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.4 | 20.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.4 | 18.6 | GO:0005521 | lamin binding(GO:0005521) |
1.4 | 7.1 | GO:0034046 | poly(G) binding(GO:0034046) |
1.4 | 4.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.4 | 41.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.4 | 5.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.4 | 11.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.4 | 8.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.4 | 7.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.4 | 2.8 | GO:2001070 | starch binding(GO:2001070) |
1.4 | 7.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.4 | 11.1 | GO:0005123 | death receptor binding(GO:0005123) |
1.4 | 11.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
1.4 | 17.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.4 | 5.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.4 | 4.1 | GO:0019002 | GMP binding(GO:0019002) |
1.4 | 9.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.4 | 12.3 | GO:0039706 | co-receptor binding(GO:0039706) |
1.4 | 6.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.4 | 4.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.4 | 8.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.4 | 5.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.4 | 4.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.4 | 5.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.3 | 4.0 | GO:0070402 | NADPH binding(GO:0070402) |
1.3 | 13.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.3 | 5.3 | GO:0035671 | enone reductase activity(GO:0035671) |
1.3 | 5.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.3 | 5.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.3 | 13.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.3 | 11.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.3 | 5.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.3 | 31.3 | GO:0050699 | WW domain binding(GO:0050699) |
1.3 | 18.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.3 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.3 | 15.6 | GO:0017022 | myosin binding(GO:0017022) |
1.3 | 11.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.3 | 3.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.3 | 15.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.3 | 3.9 | GO:0071253 | connexin binding(GO:0071253) |
1.3 | 56.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.3 | 12.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.3 | 3.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.3 | 11.5 | GO:0008828 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
1.3 | 15.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.3 | 3.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.3 | 12.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.3 | 12.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.2 | 30.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.2 | 3.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.2 | 3.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.2 | 7.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.2 | 129.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.2 | 11.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.2 | 3.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.2 | 4.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.2 | 10.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.2 | 3.6 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.2 | 4.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.2 | 11.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 12.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.2 | 7.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.2 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 5.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.2 | 11.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 2.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.2 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.2 | 2.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.2 | 5.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.2 | 4.6 | GO:0008106 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) alcohol dehydrogenase (NADP+) activity(GO:0008106) |
1.2 | 2.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.1 | 5.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
1.1 | 10.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.1 | 9.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.1 | 43.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.1 | 5.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.1 | 3.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.1 | 3.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.1 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 4.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
1.1 | 3.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.1 | 1.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.1 | 14.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.1 | 9.9 | GO:0004568 | chitinase activity(GO:0004568) |
1.1 | 4.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.1 | 6.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.1 | 3.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.1 | 27.3 | GO:0043236 | laminin binding(GO:0043236) |
1.1 | 1.1 | GO:0045182 | translation regulator activity(GO:0045182) |
1.1 | 22.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.1 | 11.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.1 | 2.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.1 | 21.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
1.1 | 8.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.1 | 2.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.1 | 1.1 | GO:0034559 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
1.1 | 4.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.1 | 2.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.1 | 2.1 | GO:0036033 | mediator complex binding(GO:0036033) |
1.1 | 15.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.0 | 6.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.0 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
1.0 | 7.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 2.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.0 | 7.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.0 | 5.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.0 | 26.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.0 | 3.1 | GO:0002046 | opsin binding(GO:0002046) |
1.0 | 1.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.0 | 3.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.0 | 1.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.0 | 3.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.0 | 42.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.0 | 2.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.0 | 13.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.0 | 3.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.0 | 11.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.0 | 8.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 4.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.0 | 3.0 | GO:0000182 | rDNA binding(GO:0000182) |
1.0 | 8.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 9.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.0 | 3.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
1.0 | 2.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.0 | 6.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.0 | 4.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.0 | 3.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 9.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.0 | 29.3 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.0 | 3.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.0 | 16.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.0 | 85.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.0 | 3.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.0 | 47.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
1.0 | 3.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.0 | 4.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.0 | 20.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.0 | 9.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.0 | 1.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.0 | 5.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 6.7 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
1.0 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 5.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.9 | 3.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.9 | 2.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.9 | 6.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.9 | 3.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.9 | 3.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.9 | 45.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.9 | 28.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.9 | 1.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 169.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.9 | 12.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.9 | 40.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.9 | 2.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 64.4 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.9 | 1.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.9 | 0.9 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.9 | 36.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.9 | 5.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 2.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 1.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 3.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.9 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.9 | 8.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.9 | 8.0 | GO:0035586 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) purinergic receptor activity(GO:0035586) |
0.9 | 3.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.9 | 29.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.9 | 3.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 0.9 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.9 | 4.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.9 | 1.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.9 | 26.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.9 | 2.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.9 | 2.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.9 | 4.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.8 | 21.1 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.8 | 147.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 6.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.8 | 48.7 | GO:0005178 | integrin binding(GO:0005178) |
0.8 | 2.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 3.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.8 | 1.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.8 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 113.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.8 | 9.9 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.8 | 5.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.8 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.8 | 2.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 1.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.8 | 34.9 | GO:0019003 | GDP binding(GO:0019003) |
0.8 | 6.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.8 | 4.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.8 | 12.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.8 | 5.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.8 | 2.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 4.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 4.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.8 | 6.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 0.8 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.8 | 3.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.8 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 7.1 | GO:0019841 | retinol binding(GO:0019841) |
0.8 | 5.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 2.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.8 | 1.5 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.8 | 4.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.8 | 8.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.8 | 4.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.8 | 15.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.8 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 3.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.8 | 6.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.7 | 2.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 5.2 | GO:0043531 | ADP binding(GO:0043531) |
0.7 | 16.4 | GO:0043621 | protein self-association(GO:0043621) |
0.7 | 7.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.7 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.7 | 4.4 | GO:0016208 | AMP binding(GO:0016208) |
0.7 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 4.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 1.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 26.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.7 | 24.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.7 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.7 | 2.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 2.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.7 | 4.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.7 | 3.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 56.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.7 | 4.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 3.3 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.7 | 44.0 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 1.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 5.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.7 | 1.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.6 | 16.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.6 | 9.0 | GO:0005504 | fatty acid binding(GO:0005504) monocarboxylic acid binding(GO:0033293) |
0.6 | 7.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 5.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 1.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.6 | 28.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.6 | 2.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 1.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.6 | 4.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.6 | 7.4 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.6 | 105.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 17.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.6 | 2.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.6 | 3.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 7.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 7.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 2.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 30.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.6 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.6 | 2.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.6 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 7.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.6 | 8.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.6 | 2.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.6 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.6 | 1.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.6 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 12.5 | GO:0019706 | S-acyltransferase activity(GO:0016417) protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 18.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 7.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.6 | 3.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 4.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.6 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 4.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.6 | 6.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.6 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 2.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.6 | 1.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 1.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 4.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 1.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 1.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.5 | 13.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.5 | 271.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.5 | 14.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 1.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 2.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 11.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 8.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 13.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.5 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 6.1 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 1.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 15.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.5 | 1.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.5 | 15.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 12.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 4.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.5 | 3.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 124.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.5 | 12.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.5 | 0.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 3.7 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.5 | 1.8 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.5 | 0.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 1.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 0.4 | GO:0008061 | chitin binding(GO:0008061) |
0.4 | 5.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 3.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.4 | 3.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 11.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 1.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.4 | 1.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 5.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 23.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.4 | 2.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 6.6 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.4 | 9.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 30.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 2.4 | GO:0009055 | electron carrier activity(GO:0009055) |
0.4 | 4.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.4 | 65.4 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 52.8 | GO:0016791 | phosphatase activity(GO:0016791) |
0.4 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 2.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.4 | 6.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 6.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.4 | 2.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 0.7 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 2.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 8.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 1.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 84.7 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.3 | 2.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 7.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 0.6 | GO:0070697 | activin receptor binding(GO:0070697) |
0.3 | 1.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 8.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 1.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 3.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 4.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 2.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 33.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.2 | 1.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 26.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.2 | 21.5 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.2 | 1.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 8.1 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.2 | 0.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 2.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.2 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.2 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.4 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 15.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 6.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 2.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.0 | GO:0042623 | ATPase activity, coupled(GO:0042623) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 3.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.7 | GO:0016877 | ligase activity, forming carbon-sulfur bonds(GO:0016877) |
0.1 | 0.6 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 3.9 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 7.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 78.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.0 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 1.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 37.2 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 55.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
3.9 | 19.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.9 | 93.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
3.8 | 91.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.6 | 67.6 | PID IGF1 PATHWAY | IGF1 pathway |
3.5 | 45.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
3.5 | 24.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.5 | 101.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.4 | 50.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.3 | 55.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
3.1 | 130.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.1 | 12.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
3.0 | 45.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
3.0 | 30.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.9 | 11.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.9 | 96.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.9 | 31.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.9 | 66.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.9 | 146.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.8 | 25.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.6 | 18.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
2.6 | 23.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.5 | 5.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.5 | 24.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.4 | 130.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
2.4 | 98.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
2.4 | 93.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.3 | 34.6 | PID IFNG PATHWAY | IFN-gamma pathway |
2.2 | 11.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
2.2 | 26.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
2.2 | 52.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.2 | 28.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.1 | 57.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.1 | 49.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
2.0 | 36.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.0 | 55.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
2.0 | 19.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.9 | 11.6 | PID BCR 5PATHWAY | BCR signaling pathway |
1.9 | 63.1 | PID P53 REGULATION PATHWAY | p53 pathway |
1.9 | 11.4 | PID BARD1 PATHWAY | BARD1 signaling events |
1.9 | 26.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.8 | 33.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
1.8 | 29.4 | PID AURORA A PATHWAY | Aurora A signaling |
1.8 | 7.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.8 | 14.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.8 | 7.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.8 | 14.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.8 | 47.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.8 | 14.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.8 | 8.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.7 | 39.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.7 | 46.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.7 | 36.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.7 | 34.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.7 | 47.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.7 | 14.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.6 | 21.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.6 | 17.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.6 | 6.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.6 | 6.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.6 | 19.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.6 | 57.4 | PID P73PATHWAY | p73 transcription factor network |
1.5 | 12.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.5 | 38.2 | PID AURORA B PATHWAY | Aurora B signaling |
1.5 | 28.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.5 | 4.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.4 | 7.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.4 | 5.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.4 | 21.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.4 | 58.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.4 | 14.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.4 | 11.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.4 | 5.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.3 | 17.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.3 | 11.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.3 | 18.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.3 | 22.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.3 | 35.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.3 | 10.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.3 | 23.0 | PID ARF6 PATHWAY | Arf6 signaling events |
1.3 | 5.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 7.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
1.2 | 2.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.2 | 30.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.2 | 12.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.2 | 1.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.2 | 4.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.2 | 33.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.1 | 26.2 | PID PLK1 PATHWAY | PLK1 signaling events |
1.1 | 3.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.1 | 2.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.1 | 60.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.0 | 2.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.0 | 12.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 9.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
1.0 | 13.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.0 | 7.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.0 | 21.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.0 | 1.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.9 | 4.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 1.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 13.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.9 | 6.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.9 | 29.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.9 | 16.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.9 | 16.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.9 | 8.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.9 | 16.2 | PID E2F PATHWAY | E2F transcription factor network |
0.8 | 4.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 5.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 3.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 19.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.8 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 5.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 2.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 5.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.7 | 8.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.7 | 3.3 | PID ATM PATHWAY | ATM pathway |
0.7 | 4.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 15.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.6 | 17.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 3.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 8.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 17.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.6 | 8.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 6.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.6 | 15.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 74.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 9.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 4.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 2.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 4.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 6.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 6.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 4.1 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 5.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 63.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 6.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 28.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
5.7 | 5.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
5.7 | 68.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
5.3 | 64.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
5.3 | 37.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
5.1 | 50.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.9 | 39.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
4.9 | 9.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
4.3 | 73.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
4.3 | 17.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
4.1 | 41.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
4.0 | 32.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.9 | 55.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.8 | 19.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
3.8 | 38.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.7 | 52.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
3.7 | 11.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
3.7 | 58.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.6 | 43.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.6 | 39.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
3.5 | 38.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
3.5 | 42.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
3.5 | 7.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
3.5 | 83.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
3.5 | 31.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
3.4 | 44.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
3.4 | 30.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.4 | 37.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
3.4 | 50.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
3.3 | 43.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
3.3 | 29.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
3.2 | 31.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.0 | 75.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.0 | 29.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.9 | 29.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.9 | 111.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
2.9 | 2.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
2.9 | 25.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.8 | 8.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
2.8 | 31.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.8 | 39.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.8 | 27.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
2.8 | 5.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
2.7 | 43.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.7 | 13.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.7 | 40.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.5 | 2.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
2.5 | 27.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.5 | 37.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.4 | 4.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.4 | 26.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.4 | 26.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.4 | 2.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.4 | 35.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.3 | 4.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
2.3 | 62.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.3 | 18.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.3 | 47.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.3 | 15.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.2 | 20.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.2 | 39.9 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
2.2 | 2.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.2 | 179.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.2 | 53.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
2.1 | 23.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.1 | 31.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
2.1 | 27.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.1 | 59.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.1 | 65.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
2.1 | 18.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.1 | 8.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
2.0 | 20.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.0 | 6.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.9 | 3.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.9 | 34.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.9 | 19.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.9 | 5.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.9 | 13.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.9 | 43.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.9 | 56.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.9 | 5.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.9 | 26.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.9 | 22.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.9 | 71.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.9 | 16.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.9 | 28.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.9 | 7.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.9 | 14.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.8 | 12.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.8 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.8 | 81.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.8 | 16.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.8 | 32.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.8 | 1.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
1.8 | 3.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.8 | 1.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.8 | 14.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.7 | 88.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.7 | 30.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.7 | 35.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.7 | 42.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.7 | 16.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.7 | 1.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.6 | 8.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.6 | 4.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.6 | 44.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.6 | 7.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.6 | 34.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.6 | 31.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.6 | 1.6 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
1.6 | 24.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
1.5 | 32.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.5 | 6.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.5 | 16.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.5 | 7.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.5 | 18.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.5 | 6.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.5 | 134.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.5 | 13.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.5 | 17.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.4 | 59.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.4 | 117.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.4 | 5.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.4 | 21.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.4 | 30.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.4 | 67.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.4 | 9.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.4 | 34.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.4 | 78.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.3 | 20.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.3 | 17.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.3 | 1.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.3 | 10.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.3 | 14.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.3 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.3 | 17.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.3 | 21.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.3 | 10.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
1.2 | 3.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.2 | 1.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
1.2 | 20.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.2 | 20.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.2 | 9.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.2 | 10.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
1.2 | 29.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.2 | 4.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.2 | 2.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.2 | 21.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.1 | 13.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.1 | 2.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.1 | 3.4 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
1.1 | 14.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.1 | 9.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.1 | 75.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.1 | 10.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.1 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.1 | 13.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.1 | 5.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.0 | 38.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.0 | 12.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
1.0 | 31.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.0 | 20.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.0 | 32.7 | REACTOME TRANSLATION | Genes involved in Translation |
1.0 | 46.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.0 | 1.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.0 | 26.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 16.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.0 | 9.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.9 | 4.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.9 | 3.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.9 | 11.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.9 | 25.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.9 | 10.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.9 | 6.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 3.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 34.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 5.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.9 | 7.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 27.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 3.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 99.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.9 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 5.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.8 | 33.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.8 | 9.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 2.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 10.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.7 | 16.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.7 | 8.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.7 | 27.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.7 | 26.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.7 | 1.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.7 | 3.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.7 | 6.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.7 | 11.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 5.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 3.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 36.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.6 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 9.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.6 | 17.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.6 | 7.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.6 | 13.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.6 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 1.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 1.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 12.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.5 | 1.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.5 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 5.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 0.5 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.5 | 3.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 7.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 3.9 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.5 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 12.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.4 | 9.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 3.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 2.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 14.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 9.3 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.4 | 4.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 1.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.4 | 33.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 4.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 8.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 1.7 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.3 | 2.7 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 0.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 1.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 1.2 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 3.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.1 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.1 | 2.8 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 1.0 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |